Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
J Virol
    February 2021
  1. ZHAO Z, Fagerlund R, Baur AS, Saksela K, et al
    HIV-1 Nef-induced secretion of the proinflammatory protease TACE into extracellularvesicles is mediated by Raf-1, and can be suppressed by clinical protein kinase inhibitors.
    J Virol. 2021 Feb 17. pii: JVI.00180-21. doi: 10.1128/JVI.00180.
    >> Share

  2. PIERINI V, Gallucci L, Sturzel CM, Kirchhoff F, et al
    SERINC5 can Enhance Pro-inflammatory Cytokine Production by Primary Human Myeloid Cells in Response to Challenge with HIV-1 Particles.
    J Virol. 2021 Feb 17. pii: JVI.02372-20. doi: 10.1128/JVI.02372.
    >> Share

  3. MAVIGNER M, Liao LE, Brooks AD, Ke R, et al
    CD8 lymphocyte depletion enhances the latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques.
    J Virol. 2021 Feb 10. pii: JVI.01429-20. doi: 10.1128/JVI.01429.
    >> Share

  4. LEVY Y, Lacabaratz C, Lhomme E, Wiedemann A, et al
    A randomized placebo-controlled efficacy study of a prime boost therapeutic vaccination strategy in HIV-1 infected individuals: VRI02 ANRS 149 LIGHT Phase II trial.
    J Virol. 2021 Feb 10. pii: JVI.02165-20. doi: 10.1128/JVI.02165.
    >> Share

  5. ZIANI W, Bauer A, Lu H, Wang X, et al
    Immune responses and viral persistence in SHIV.C.CH848-infected rhesus macaques.
    J Virol. 2021 Feb 10. pii: JVI.02198-20. doi: 10.1128/JVI.02198.
    >> Share

  6. SANDSTROM TS, Ranganath N, Burke Schinkel SC, Salahuddin S, et al
    HIV-infected macrophages are infected and killed by the interferon-sensitive Rhabdovirus, MG1.
    J Virol. 2021 Feb 10. pii: JVI.01953-20. doi: 10.1128/JVI.01953.
    >> Share

  7. GRAMATICA A, Schwarzer R, Brantley W, Varco-Merth B, et al
    Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In Vivo.
    J Virol. 2021 Feb 3. pii: JVI.02393-20. doi: 10.1128/JVI.02393.
    >> Share

  8. PILKINTON MA, McDonnell WJ, Barnett L, Chopra A, et al
    In chronic infection, HIV gag-specific CD4+ T cell receptor diversity is higher than CD8+ T cell receptor diversity and is associated with less HIV quasispecies diversity.
    J Virol. 2021 Feb 3. pii: JVI.02380-20. doi: 10.1128/JVI.02380.
    >> Share

  9. ARACHCHIGE SP, Henke W, Kalamvoki M, Stephens EB, et al
    Structural Domains of the Herpes Simplex Type 1 gD Protein that Restrict HIV-1 Particle Infectivity.
    J Virol. 2021 Feb 3. pii: JVI.02355-20. doi: 10.1128/JVI.02355.
    >> Share

    January 2021
  10. MATSUI H, Shirakawa K, Konishi Y, Hirabayashi S, et al
    CAGE-seq reveals that HIV-1 latent infection does not trigger unique cellular responses in a Jurkat T cell model.
    J Virol. 2021 Jan 27. pii: JVI.02394-20. doi: 10.1128/JVI.02394.
    >> Share

  11. JANAKA SK, Palumbo AV, Tavakoli-Tameh A, Evans DT, et al
    Selective Disruption of SERINC5 Antagonism by Nef Impairs SIV Replication in Primary CD4(+) T Cells.
    J Virol. 2021 Jan 27. pii: JVI.01911-20. doi: 10.1128/JVI.01911.
    >> Share

  12. PUSNIK J, Fischinger S, Dittmer U, Esser S, et al
    Production of HIV-1 Env-specific antibodies mediating innate immune functions depends on cognate IL-21- secreting CD4+ T cells.
    J Virol. 2021 Jan 27. pii: JVI.02097-20. doi: 10.1128/JVI.02097.
    >> Share

  13. VIGLIANTI GA, Planelles V, Hanley TM
    Interactions with Commensal and Pathogenic Bacteria Induce HIV-1 Latency in Macrophages through Altered Transcription Factor Recruitment to the LTR.
    J Virol. 2021 Jan 20. pii: JVI.02141-20. doi: 10.1128/JVI.02141.
    >> Share

  14. MAYBERRY CL, Wilczek MP, Fong TM, Nichols SL, et al
    GRK2 mediates beta-arrestin interactions with 5-HT2 receptors for JC polyomavirus endocytosis.
    J Virol. 2021 Jan 13. pii: JVI.02139-20. doi: 10.1128/JVI.02139.
    >> Share

  15. SARABIA I, Huang SH, Ward AR, Jones RB, et al
    The Intact Non-Inducible Latent HIV-1 Reservoir is Established In an In Vitro Primary TCM Cell Model of Latency.
    J Virol. 2021 Jan 13. pii: JVI.01297-20. doi: 10.1128/JVI.01297.
    >> Share

  16. MATSUOKA S, Kuwata T, Ishii H, Sekizuka T, et al
    A Potent anti-Simian Immunodeficiency Virus Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Rhesus Macaques.
    J Virol. 2021 Jan 13. pii: JVI.02455-20. doi: 10.1128/JVI.02455.
    >> Share

  17. SANGARE K, Tuero I, Rahman MA, Hoang T, et al
    The immunological impact of adenovirus early genes on vaccine-induced responses in mice and nonhuman primates.
    J Virol. 2021 Jan 13. pii: JVI.02253-20. doi: 10.1128/JVI.02253.
    >> Share

  18. ZIANI W, Shao J, Wang X, Russell-Lodrigue K, et al
    Increased proviral DNA in circulating cells correlates with plasma viral rebound in SIV-infected rhesus macaques after antiretroviral therapy interruption.
    J Virol. 2021 Jan 6. pii: JVI.02064-20. doi: 10.1128/JVI.02064.
    >> Share

    December 2020
  19. ZHANG Y, Murakoshi H, Chikata T, Akahoshi T, et al
    Effect of difference in consensus sequence between HIV-1 subtype A/E and subtype B viruses on elicitation of Gag-specific CD8(+) T cells and accumulation of HLA-associated escape mutations.
    J Virol. 2020 Dec 23. pii: JVI.02061-20. doi: 10.1128/JVI.02061.
    >> Share

  20. SANZ M, Madrid-Elena N, Serrano-Villar S, Vallejo A, et al
    Effect of the use of Galectin-9 and blockade of TIM-3 receptor in the latent cellular reservoir of HIV-1.
    J Virol. 2020 Dec 23. pii: JVI.02214-20. doi: 10.1128/JVI.02214.
    >> Share

  21. GAEBLER C, Falcinelli SD, Stoffel E, Read J, et al
    Sequence evaluation and comparative analysis of novel assays for intact proviral HIV-1 DNA.
    J Virol. 2020 Dec 23. pii: JVI.01986-20. doi: 10.1128/JVI.01986.
    >> Share

  22. ACHARYA A, Olwenyi OA, Thurman M, Pandey K, et al
    Chronic morphine administration differentially modulates viral reservoirs in SIVmac251 infected rhesus macaque model.
    J Virol. 2020 Dec 16. pii: JVI.01657-20. doi: 10.1128/JVI.01657.
    >> Share

  23. AKIYAMA H, Jalloh S, Park S, Lei M, et al
    Expression of HIV-1 Intron-Containing RNA in Microglia Induces Inflammatory Responses.
    J Virol. 2020 Dec 9. pii: JVI.01386-20. doi: 10.1128/JVI.01386.
    >> Share

  24. LORENZI JCC, Mendoza P, Cohen YZ, Nogueira L, et al
    Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates.
    J Virol. 2020 Dec 9. pii: JVI.01909-20. doi: 10.1128/JVI.01909.
    >> Share

  25. VEZINA D, Gong SY, Tolbert WD, Ding S, et al
    Stabilizing the HIV-1 envelope glycoprotein State 2A conformation.
    J Virol. 2020 Dec 9. pii: JVI.01620-20. doi: 10.1128/JVI.01620.
    >> Share

  26. DROUIN A, Migraine J, Durand MA, Moreau A, et al
    Escape of HIV-1 envelope glycoprotein from the restriction of infection by IFITM3.
    J Virol. 2020 Dec 9. pii: JVI.01994-20. doi: 10.1128/JVI.01994.
    >> Share

    November 2020
  27. MORI L, Jenike K, Yeh YJ, Lacombe B, et al
    The XPB Subunit of the TFIIH Complex Plays a Critical Role in HIV-1 Transcription and XPB Inhibition by Spironolactone Prevents HIV-1 Reactivation from Latency.
    J Virol. 2020 Nov 25. pii: JVI.01247-20. doi: 10.1128/JVI.01247.
    >> Share

  28. KLEIN K, Nankya I, Nickel G, Ratcliff AN, et al
    Deep gene sequence cluster analyses of multi-virus infected mucosal tissue reveal enhanced transmission of acute HIV-1.
    J Virol. 2020 Nov 11. pii: JVI.01737-20. doi: 10.1128/JVI.01737.
    >> Share

  29. ESPADA CE, St Gelais C, Bonifati S, Maksimova VV, et al
    TRAF6 and TAK1 contribute to SAMHD1-mediated negative regulation of NF-kappaB signaling.
    J Virol. 2020 Nov 11. pii: JVI.01970-20. doi: 10.1128/JVI.01970.
    >> Share

  30. BERENDAM SJ, Styles TM, Morgan-Asiedu PK, Tenney D, et al
    Systematic assessment of antiviral potency, breadth, and synergy of triple broadly neutralizing antibody combinations against Simian-Human Immunodeficiency Viruses.
    J Virol. 2020 Nov 11. pii: JVI.01667-20. doi: 10.1128/JVI.01667.
    >> Share

  31. REED JC, Solas D, Kitaygorodskyy A, Freeman B, et al
    Identification of an antiretroviral small molecule that appears to be a host-targeting inhibitor of HIV-1 assembly.
    J Virol. 2020 Nov 4. pii: JVI.00883-20. doi: 10.1128/JVI.00883.
    >> Share

  32. ZHANG S, Nguyen HT, Ding H, Wang J, et al
    Dual pathways of human immunodeficiency virus (HIV-1) envelope glycoprotein trafficking modulate the selective exclusion of uncleaved oligomers from virions.
    J Virol. 2020 Nov 4. pii: JVI.01369-20. doi: 10.1128/JVI.01369.
    >> Share

    October 2020
  33. DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
    A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.
    J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
    >> Share

  34. REN Y, Korom M, Ward AR, Truong R, et al
    Relationships between Neutralization, Binding, and ADCC of Broadly Neutralizing Antibodies against Reservoir HIV.
    J Virol. 2020 Oct 28. pii: JVI.01808-20. doi: 10.1128/JVI.01808.
    >> Share

  35. ESCHBACH JE, Elliott JL, Li W, Zadrozny KK, et al
    Capsid lattice destabilization leads to premature loss of the viral genome and integrase enzyme during HIV-1 infection.
    J Virol. 2020 Oct 28. pii: JVI.00984-20. doi: 10.1128/JVI.00984.
    >> Share

  36. YUKL SA, Khan S, Chen TH, Trapecar M, et al
    Shared Mechanisms Govern HIV Transcriptional Suppression in Circulating CD103+ and Gut CD4+ T Cells.
    J Virol. 2020 Oct 28. pii: JVI.01331-20. doi: 10.1128/JVI.01331.
    >> Share

  37. ELENA GOMEZ C, Perdiguero B, Falqui M, Quiros M, et al
    Enhancement of HIV-1 Env-specific CD8 T cell responses using IFN-Stimulated Gene 15 (ISG15) as an immune adjuvant.
    J Virol. 2020 Oct 28. pii: JVI.01155-20. doi: 10.1128/JVI.01155.
    >> Share

  38. LU M, Ma X, Reichard N, Terry DS, et al
    Correction for Lu et al., "Shedding-Resistant HIV-1 Envelope Glycoproteins Adopt Downstream Conformations That Remain Responsive to Conformation-Preferring Ligands".
    J Virol. 2020;94.
    >> Share

  39. DEVASUNDARAM S, Rosati M, Valentin A, Weiss S, et al
    Priming with DNA expressing trimeric HIV V1V2 alters the immune hierarchy favoring the development of V2-specific antibodies in rhesus macaques.
    J Virol. 2020 Oct 21. pii: JVI.01193-20. doi: 10.1128/JVI.01193.
    >> Share

  40. KATO S, Shida H, Okamura T, Zhang X, et al
    CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
    J Virol. 2020 Oct 21. pii: JVI.01718-20. doi: 10.1128/JVI.01718.
    >> Share

  41. OBREGON-PERKO V, Bricker K, Mensah G, Uddin F, et al
    SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques is Characterized by Elevated SHIV RNA in the Gut and High Abundance of Intact SHIV DNA in Naive CD4+ T cells.
    J Virol. 2020 Oct 21. pii: JVI.01669-20. doi: 10.1128/JVI.01669.
    >> Share

  42. HEMELAAR J, Loganathan S, Elangovan R, Yun J, et al
    Country-level diversity of the HIV-1 pandemic between 1990 and 2015.
    J Virol. 2020 Oct 21. pii: JVI.01580-20. doi: 10.1128/JVI.01580.
    >> Share

  43. MARTINS MA, Gonzalez-Nieto L, Ricciardi MJ, Bailey VK, et al
    Rectal Acquisition of SIVmac239 Infection Despite Vaccine-Induced Immune Responses Against the Entire SIV Proteome.
    J Virol. 2020 Oct 7. pii: JVI.00979-20. doi: 10.1128/JVI.00979.
    >> Share

  44. STINN T, Kuntz S, Varon D, Huang ML, et al
    Subclinical genital herpes shedding in HIV/HSV-2 co-infected women during antiretroviral therapy (ART) is associated with an increase in HIV tissue reservoirs and potentially promotes HIV evolution.
    J Virol. 2020 Oct 7. pii: JVI.01606-20. doi: 10.1128/JVI.01606.
    >> Share

    September 2020
  45. SCHORCHT A, van den Kerkhof TLGM, Cottrell CA, Allen JD, et al
    Neutralizing antibody responses induced by HIV-1 envelope glycoprotein SOSIP trimers derived from elite neutralizers.
    J Virol. 2020 Sep 30. pii: JVI.01214-20. doi: 10.1128/JVI.01214.
    >> Share

  46. MAHE D, Matusali G, Deleage C, Alvarenga RLLS, et al
    Potential for virus endogenization in humans through testicular germ cell infection: the case of HIV.
    J Virol. 2020 Sep 30. pii: JVI.01145-20. doi: 10.1128/JVI.01145.
    >> Share

  47. MEZIANE O, Salahuddin S, Pham TNQ, Farnos O, et al
    HIV infection and persistence in pulmonary mucosal double negative T-cells in vivo.
    J Virol. 2020 Sep 23. pii: JVI.01788-20. doi: 10.1128/JVI.01788.
    >> Share

  48. MUSICH T, Thovarai V, Venzon DJ, Mohanram V, et al
    A prime/boost vaccine regimen alters the rectal microbiome and impacts immune responses and viremia control post-SIV infection in male and female rhesus macaques.
    J Virol. 2020 Sep 23. pii: JVI.01225-20. doi: 10.1128/JVI.01225.
    >> Share

  49. FERNANDEZ MV, Hoffman HK, Pezeshkian N, Tedbury PR, et al
    Elucidating the basis for permissivity of the MT-4 T-cell line to replication of an HIV-1 mutant lacking the gp41 cytoplasmic tail.
    J Virol. 2020 Sep 16. pii: JVI.01334-20. doi: 10.1128/JVI.01334.
    >> Share

  50. VRANCKEN B, Zhao B, Li X, Han X, et al
    COMPARATIVE CIRCULATION DYNAMICS OF THE FIVE MAIN HIV TYPES IN CHINA.
    J Virol. 2020 Sep 16. pii: JVI.00683-20. doi: 10.1128/JVI.00683.
    >> Share

  51. STEINER F, Pavlovic J
    Subcellular localization of MxB determines its antiviral potential against influenza A virus.
    J Virol. 2020 Sep 9. pii: JVI.00125-20. doi: 10.1128/JVI.00125.
    >> Share

  52. HOFFMANN AR, Guha S, Wu E, Ghimire J, et al
    Broad-Spectrum Antiviral Entry Inhibition by Interfacially-Active Peptides.
    J Virol. 2020 Sep 9. pii: JVI.01682-20. doi: 10.1128/JVI.01682.
    >> Share

  53. MIGUELES SA, Rogan DC, Gavil NV, Kelly EP, et al
    Antigenic Re-Stimulation of Virus-Specific Memory CD8(+) T Cells Requires Days of Lytic Protein Accumulation for Maximal Cytotoxic Capacity.
    J Virol. 2020 Sep 9. pii: JVI.01595-20. doi: 10.1128/JVI.01595.
    >> Share

  54. TWIZERIMANA AP, Scheck R, Becker D, Zhang Z, et al
    Cell type-dependent escape of capsid inhibitors by simian immunodeficiency virus SIVcpz.
    J Virol. 2020 Sep 9. pii: JVI.01338-20. doi: 10.1128/JVI.01338.
    >> Share

  55. RABEZANAHARY H, Clain J, Racine G, Andreani G, et al
    Early antiretroviral therapy prevents viral infection of monocytes and inflammation in SIV-infected rhesus macaques.
    J Virol. 2020 Sep 9. pii: JVI.01478-20. doi: 10.1128/JVI.01478.
    >> Share

  56. ARORA R, Liew CW, Soh TS, Otoo DA, et al
    Two RNA tunnel inhibitors bind in highly conserved sites in Dengue virus NS5 polymerase: structural and functional studies.
    J Virol. 2020 Sep 9. pii: JVI.01130-20. doi: 10.1128/JVI.01130.
    >> Share

  57. KHANAL S, Tang Q, Cao D, Zhao J, et al
    Telomere and ATM dynamics in CD4 T cell depletion in active and virus-suppressed HIV infection.
    J Virol. 2020 Sep 9. pii: JVI.01061-20. doi: 10.1128/JVI.01061.
    >> Share

    August 2020
  58. SALAMANGO DJ, McCann JL, Demir O, Becker JT, et al
    Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated using Patient HIV-1 Isolates and Computational Modeling.
    J Virol. 2020 Aug 26. pii: JVI.00631-20. doi: 10.1128/JVI.00631.
    >> Share

  59. JORDAN-PAIZ A, Nevot M, Lamkiewicz K, Lataretu M, et al
    HIV-1 lethality and loss of Env protein expression induced by single synonymous substitutions in the virus genome intronic splicing silencer.
    J Virol. 2020 Aug 19. pii: JVI.01108-20. doi: 10.1128/JVI.01108.
    >> Share

  60. DAS R, Datta R, Varadarajan R
    Probing the structure of the HIV-1 Envelope trimer using Aspartate Scanning Mutagenesis.
    J Virol. 2020 Aug 19. pii: JVI.01426-20. doi: 10.1128/JVI.01426.
    >> Share

  61. ALAM SM, Cronin K, Parks R, Anasti K, et al
    Antigenicity and Immunogenicity of HIV-1 Envelope Trimers complexed to a Small-Molecule Viral Entry Inhibitor.
    J Virol. 2020 Aug 19. pii: JVI.00958-20. doi: 10.1128/JVI.00958.
    >> Share

  62. DASHTI A, Waller C, Mavigner M, Schoof N, et al
    SMAC mimetic plus triple combination bispecific HIVxCD3 DART(R) molecules in SHIV.C.CH505-infected, ART-suppressed rhesus macaques.
    J Virol. 2020 Aug 19. pii: JVI.00793-20. doi: 10.1128/JVI.00793.
    >> Share

  63. FEATHERSTONE A, Aiken C
    SERINC5 Inhibits HIV-1 Infectivity by Altering the Conformation of gp120 on HIV-1 Particles.
    J Virol. 2020 Aug 12. pii: JVI.00594-20. doi: 10.1128/JVI.00594.
    >> Share

  64. TEODOROF-DIEDRICH C, Spector SA
    Human Immunodeficiency Virus Type-1 and Methamphetamine Mediated Mitochondrial Damage and Neuronal Degeneration in Human Neurons.
    J Virol. 2020 Aug 12. pii: JVI.00924-20. doi: 10.1128/JVI.00924.
    >> Share

  65. NIKOLAITCHIK OA, Somoulay X, Rawson JMO, Yoo JA, et al
    Unpaired Guanosines in the 5' Untranslated Region of HIV-1 RNA Act Synergistically to Mediate Genome Packaging.
    J Virol. 2020 Aug 12. pii: JVI.00439-20. doi: 10.1128/JVI.00439.
    >> Share

  66. PRCHAL J, Sys J, Junkova P, Lipov J, et al
    The interaction interface of Mason-Pfizer monkey virus matrix and envelope proteins.
    J Virol. 2020 Aug 12. pii: JVI.01146-20. doi: 10.1128/JVI.01146.
    >> Share

  67. JOHNSON MC, Lyddon TD, Suarez R, Salcedo B, et al
    Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein.
    J Virol. 2020 Aug 11. pii: JVI.01062-20. doi: 10.1128/JVI.01062.
    >> Share

  68. ST BERNARD L, Abolade J, Mohri H, Markowitz M, et al
    Drug-resistance mutation frequency of SGA-derived HIV-1 polymerase genomes in the CSF and plasma of HIV-1-infected individuals under non-suppressive therapy.
    J Virol. 2020 Aug 5. pii: JVI.01824-19. doi: 10.1128/JVI.01824.
    >> Share

  69. CHANG YM, Wieland A, Li ZR, Im SJ, et al
    T cell receptor diversity and lineage relationship between virus-specific CD8 T cell subsets during chronic LCMV infection.
    J Virol. 2020 Aug 5. pii: JVI.00935-20. doi: 10.1128/JVI.00935.
    >> Share

    July 2020
  70. KANJA M, Cappy P, Levy N, Oladosu O, et al
    NKNK: a New Essential Motif in the C-Terminal Domain of HIV-1 Group M Integrases.
    J Virol. 2020 Jul 29. pii: JVI.01035-20. doi: 10.1128/JVI.01035.
    >> Share

  71. DOSTALKOVA A, Kaufman F, Krizova I, Vokata B, et al
    In vitro quantification of the effects of IP6 and other small polyanions on immature HIV-1 particle assembly and core stability.
    J Virol. 2020 Jul 29. pii: JVI.00991-20. doi: 10.1128/JVI.00991.
    >> Share

  72. ZHANG Y, Kuse N, Akahoshi T, Chikata T, et al
    Role of escape mutant-specific T cells in suppression of HIV-1 replication and co-evolution with HIV-1.
    J Virol. 2020 Jul 22. pii: JVI.01151-20. doi: 10.1128/JVI.01151.
    >> Share

  73. GARCIA-MESA Y, Garza R, Diaz Ortiz ME, Gruenewald AL, et al
    Regional brain recovery from acute synaptic injury in SIV-infected rhesus macaques associates with heme oxygenase isoform expression.
    J Virol. 2020 Jul 15. pii: JVI.01102-20. doi: 10.1128/JVI.01102.
    >> Share

  74. CHAKRABORTY S, Kabi M, Ranga U
    A stronger transcription regulatory circuit of HIV-1C drives the rapid establishment of latency with implications for the direct involvement of Tat.
    J Virol. 2020 Jul 15. pii: JVI.00503-20. doi: 10.1128/JVI.00503.
    >> Share

  75. MISHRA N, Sharma S, Dobhal A, Kumar S, et al
    A rare mutation in an infant derived HIV-1 envelope glycoprotein alters interprotomer stability and susceptibility to broadly neutralizing antibodies targeting the trimer apex.
    J Virol. 2020 Jul 15. pii: JVI.00814-20. doi: 10.1128/JVI.00814.
    >> Share

  76. MCBRIEN JB, Wong AKH, White E, Carnathan DG, et al
    Combination of CD8beta depletion and IL-15 superagonist N-803 induces virus reactivation in SHIV-infected, long-term ART-treated rhesus macaques.
    J Virol. 2020 Jul 15. pii: JVI.00755-20. doi: 10.1128/JVI.00755.
    >> Share

  77. SIVANANDHAM R, Kleinman AJ, Sette P, Brocca-Cofano E, et al
    Nonhuman Primate Testing of the Impact of Different Treg Depletion Strategies on Reactivation and Clearance of Latent Simian Immunodeficiency Virus.
    J Virol. 2020 Jul 15. pii: JVI.00533-20. doi: 10.1128/JVI.00533.
    >> Share

  78. CHAILLON A, Nakazawa M, Rawlings SA, Curtin G, et al
    Subclinical CMV and EBV Shedding is associated with increasing HIV DNA Molecular Diversity in Peripheral Blood during Suppressive Antiretroviral Therapy.
    J Virol. 2020 Jul 8. pii: JVI.00927-20. doi: 10.1128/JVI.00927.
    >> Share

  79. ZHAO X, Zheng S, Chen D, Zheng M, et al
    LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
    J Virol. 2020 Jul 8. pii: JVI.00562-20. doi: 10.1128/JVI.00562.
    >> Share

  80. ZHAO W, Akkawi C, Mougel M, Ross SR, et al
    Murine leukemia virus P50 protein counteracts APOBEC3 by blocking its packaging.
    J Virol. 2020 Jul 8. pii: JVI.00032-20. doi: 10.1128/JVI.00032.
    >> Share

  81. NAKAMURA T, Nakamura T, Amano M, Miyakawa T, et al
    A conformational escape reaction of HIV-1 against an allosteric integrase inhibitor.
    J Virol. 2020 Jul 1. pii: JVI.00486-20. doi: 10.1128/JVI.00486.
    >> Share

    June 2020
  82. WANG H, Liu Y, Huan C, Yang J, et al
    Long noncoding RNA NKILA regulates HIV-1 replication and latency through repressing NF-kB signaling.
    J Virol. 2020 Jun 24. pii: JVI.01057-20. doi: 10.1128/JVI.01057.
    >> Share

  83. POWELL RL, Weiss S, Fox A, Liu X, et al
    An HIV vaccine targeting the V2 region of Envelope induces a highly durable polyfunctional Fc-mediated antibody response in rhesus macaques.
    J Virol. 2020 Jun 17. pii: JVI.01175-20. doi: 10.1128/JVI.01175.
    >> Share

  84. RAWAT P, Hon S, Teodorof-Diedrich C, Spector SA, et al
    Trehalose Inhibits Human Immunodeficiency Virus type-1 Infection in Primary Human Macrophages and CD4(+) T lymphocytes through Two Distinct Mechanisms.
    J Virol. 2020 Jun 17. pii: JVI.00237-20. doi: 10.1128/JVI.00237.
    >> Share

  85. LU M, Ma X, Reichard N, Terry DS, et al
    Shedding-resistant HIV-1 envelope glycoproteins adopt downstream conformations that remain responsive to conformation-preferring ligands.
    J Virol. 2020 Jun 10. pii: JVI.00597-20. doi: 10.1128/JVI.00597.
    >> Share

  86. THAMAMONGOOD T, Aebischer A, Wagner V, Chang MW, et al
    A genome-wide CRISPR-Cas9 screen reveals the requirement of host cell sulfation for Schmallenberg virus infection.
    J Virol. 2020 Jun 10. pii: JVI.00752-20. doi: 10.1128/JVI.00752.
    >> Share

  87. BEITARI S, Pan Q, Finzi A, Liang C, et al
    Differential pressures of SERINC5 and IFITM3 on HIV-1 envelope glycoprotein over the course of HIV-1 infection.
    J Virol. 2020 Jun 3. pii: JVI.00514-20. doi: 10.1128/JVI.00514.
    >> Share

    May 2020
  88. CHEMUDUPATI M, Kenney AD, Smith AC, Fillinger RJ, et al
    Butyrate reprograms expression of specific interferon stimulated genes.
    J Virol. 2020 May 27. pii: JVI.00326-20. doi: 10.1128/JVI.00326.
    >> Share

  89. EL-BADRY E, Macharia G, Claiborne D, Brooks K, et al
    Better viral control despite higher CD4(+) T cell activation during acute HIV-1 infection in Zambian women is linked to the sex hormone estradiol.
    J Virol. 2020 May 27. pii: JVI.00758-20. doi: 10.1128/JVI.00758.
    >> Share

  90. MEDIOUNI S, Jablonski JA, Tsuda S, Barsamian A, et al
    Oregano oil and its principal component carvacrol inhibit HIV-1 fusion into target cells.
    J Virol. 2020 May 27. pii: JVI.00147-20. doi: 10.1128/JVI.00147.
    >> Share

  91. MARQUES DE MENEZES EG, Jang K, George AF, Nyegaard M, et al
    Seminal plasma-derived extracellular vesicle fractions from HIV-infected men exhibit unique miRNA signatures and induce a pro-inflammatory response in cells isolated from the female reproductive tract.
    J Virol. 2020 May 20. pii: JVI.00525-20. doi: 10.1128/JVI.00525.
    >> Share

  92. GIANELLA S, Chaillon A, Chun TW, Sneller MC, et al
    HIV RNA Rebound in Seminal Plasma after Antiretroviral Treatment Interruption.
    J Virol. 2020 May 20. pii: JVI.00415-20. doi: 10.1128/JVI.00415.
    >> Share

  93. GARRIDO C, Abad-Fernandez M, Tuyishime M, Pollara JJ, et al
    Correction for Garrido et al., "Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo".
    J Virol. 2020;94.
    >> Share

  94. YU D, Xue J, Wei H, Cong Z, et al
    Therapeutic efficacy and resistance selection of a lipopeptide fusion inhibitor in simian immunodeficiency virus (SIV)-infected rhesus macaques.
    J Virol. 2020 May 13. pii: JVI.00384-20. doi: 10.1128/JVI.00384.
    >> Share

  95. LI M, Cheng S, Ding Y, Wang C, et al
    A PEG40 Modified Peptide with High Therapeutic Efficacy in SHIV Acute Infected Rhesus Monkeys.
    J Virol. 2020 May 13. pii: JVI.00386-20. doi: 10.1128/JVI.00386.
    >> Share

  96. UMVILIGIHOZO G, Cobarrubias KD, Chandrarathna S, Jin SW, et al
    Differential Vpu-mediated CD4 and tetherin downregulation function among major HIV-1 group M subtypes.
    J Virol. 2020 May 6. pii: JVI.00293-20. doi: 10.1128/JVI.00293.
    >> Share

  97. MITRA S, Shanmugapriya S, Santos da Silva E, Naghavi MH, et al
    HIV-1 exploits CLASP2 to induce microtubule stabilization and facilitate virus trafficking to the nucleus.
    J Virol. 2020 May 6. pii: JVI.00404-20. doi: 10.1128/JVI.00404.
    >> Share

  98. GONZALES B, de Rocquigny H, Beziau A, Durand S, et al
    Type I phosphatidylinositol-4-phosphate 5-kinase alpha and gamma play a key role in targeting HIV-1 Pr55(Gag) to the plasma membrane.
    J Virol. 2020 May 6. pii: JVI.00189-20. doi: 10.1128/JVI.00189.
    >> Share

    April 2020
  99. SCHARF L, Tauriainen J, Buggert M, Hartogensis W, et al
    Delayed expression of PD1 and TIGIT on HIV-specific CD8 T-cells in untreated HLA-B*57:01 individuals followed from early infection.
    J Virol. 2020 Apr 29. pii: JVI.02128-19. doi: 10.1128/JVI.02128.
    >> Share

  100. MIKHAILOVA A, Valle-Casuso JC, David A, Monceaux V, et al
    Anti-apoptotic clone 11 derived peptides induce in vitro death of CD4+ T cells susceptible to HIV-1 infection.
    J Virol. 2020 Apr 29. pii: JVI.00611-20. doi: 10.1128/JVI.00611.
    >> Share

  101. STRONGIN Z, Micci L, Fromentin R, Harper J, et al
    Virologic and immunologic features of SIV control post ART interruption in rhesus macaques.
    J Virol. 2020 Apr 29. pii: JVI.00338-20. doi: 10.1128/JVI.00338.
    >> Share

  102. TSAI MC, Singh S, Adland E, Goulder P, et al
    IMPACT OF HLA-B*52:01-DRIVEN ESCAPE MUTATIONS ON VIRAL REPLICATIVE CAPACITY.
    J Virol. 2020 Apr 22. pii: JVI.02025-19. doi: 10.1128/JVI.02025.
    >> Share

  103. MAXWELL JW, Falcinelli SD, Nefedov A, Dorfmeier C, et al
    Cellular gene modulation of HIV infected CD4 T cells in response to serial treatment with the histone deacetylase (HDAC) inhibitor vorinostat.
    J Virol. 2020 Apr 15. pii: JVI.00351-20. doi: 10.1128/JVI.00351.
    >> Share

  104. CHUANG GY, Lai YT, Boyington JC, Cheng C, et al
    Development of a 3Mut-Apex-Stabilized Envelope Trimer that Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses.
    J Virol. 2020 Apr 15. pii: JVI.00074-20. doi: 10.1128/JVI.00074.
    >> Share

  105. MAEDA Y, Takemura T, Chikata T, Kuwata T, et al
    Existence of replication-competent minor variants with different coreceptor usage in plasma from HIV-1-infected individuals.
    J Virol. 2020 Apr 15. pii: JVI.00193-20. doi: 10.1128/JVI.00193.
    >> Share

  106. COUNCIL OD, Zhou S, McCann CD, Hoffman I, et al
    Deep Sequencing Reveals Compartmentalized HIV-1 in the Semen of Men With and Without STI-Associated Urethritis.
    J Virol. 2020 Apr 8. pii: JVI.00151-20. doi: 10.1128/JVI.00151.
    >> Share

  107. KARIUKI SM, Selhorst P, Anthony C, Matten D, et al
    Compartmentalization and clonal amplification of HIV-1 in the male genital tract characterized using next generation sequencing.
    J Virol. 2020 Apr 8. pii: JVI.00229-20. doi: 10.1128/JVI.00229.
    >> Share

  108. KRCHLIKOVA V, Fabryova H, Hron T, Young JM, et al
    Antiviral Activity and Adaptive Evolution of Avian Tetherins.
    J Virol. 2020 Apr 1. pii: JVI.00416-20. doi: 10.1128/JVI.00416.
    >> Share

  109. BLANCO-RODRIGUEZ G, Gazi A, Monel B, Frabetti S, et al
    Remodeling of the core leads HIV-1 pre-integration complex in the nucleus of human lymphocytes.
    J Virol. 2020 Apr 1. pii: JVI.00135-20. doi: 10.1128/JVI.00135.
    >> Share

    March 2020
  110. DEL VECCHIO C, Celestino M, Celegato M, Palu G, et al
    Alix rescues budding of Feline Immunodeficiency Virus distinctly from Human Immunodeficiency Virus.
    J Virol. 2020 Mar 25. pii: JVI.02019-19. doi: 10.1128/JVI.02019.
    >> Share

  111. ALAMER E, Zhong C, Liu Z, Niu Q, et al
    Epigenetic suppression of HIV in myeloid cells by the BRD4-selective small molecule modulator ZL0580.
    J Virol. 2020 Mar 18. pii: JVI.01880-19. doi: 10.1128/JVI.01880.
    >> Share

  112. OLLERTON MT, Berger EA, Connick E, Burton GF, et al
    HIV-1-Specific CAR-T Cells Fail to Recognize and Eliminate the Follicular Dendritic Cell (FDC) HIV Reservoir In Vitro.
    J Virol. 2020 Mar 11. pii: JVI.00190-20. doi: 10.1128/JVI.00190.
    >> Share

  113. ZOU S, Zhang S, Gaffney A, Ding H, et al
    Long-Acting BMS-378806 Analogues Stabilize the State-1 Conformation of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoproteins.
    J Virol. 2020 Mar 11. pii: JVI.00148-20. doi: 10.1128/JVI.00148.
    >> Share

  114. HE Z, Jing S, Yang T, Chen J, et al
    PIWIL4 Maintains HIV-1 Latency by Enforcing Epigenetically Suppressive Modifications on the 5' Long Terminal Repeat (LTR).
    J Virol. 2020 Mar 11. pii: JVI.01923-19. doi: 10.1128/JVI.01923.
    >> Share

  115. TARTAGLIA LJ, Gupte S, Pastores KC, Trott S, et al
    Differential Outcomes Following Optimization of Simian-Human Immunodeficiency Viruses From Clades AE, B and C.
    J Virol. 2020 Mar 4. pii: JVI.01860-19. doi: 10.1128/JVI.01860.
    >> Share

    February 2020
  116. JOHNSON J, Flores MG, Rosa J, Han C, et al
    The High Content of Fructose in Human Semen Competitively Inhibits Broad and Potent Antivirals that Target High-mannose Glycans.
    J Virol. 2020 Feb 26. pii: JVI.01749-19. doi: 10.1128/JVI.01749.
    >> Share

  117. BAYLISS R, Wheeldon J, Caucheteux SM, Niessen CM, et al
    Identification of host trafficking genes required for HIV-1 virological synapse formation in dendritic cells.
    J Virol. 2020 Feb 19. pii: JVI.01597-19. doi: 10.1128/JVI.01597.
    >> Share

  118. DOEPKER LE, Simonich CA, Ralph D, Shipley MM, et al
    Diversity and function of maternal HIV-1-specific antibodies at the time of vertical transmission.
    J Virol. 2020 Feb 19. pii: JVI.01594-19. doi: 10.1128/JVI.01594.
    >> Share

  119. XU N, Yang J, Zheng B, Zhang Y, et al
    The pyrimidine analog FNC potently inhibits the replication of multiple enteroviruses.
    J Virol. 2020 Feb 19. pii: JVI.00204-20. doi: 10.1128/JVI.00204.
    >> Share

  120. DE GROOT NG, Heijmans CMC, de Ru AH, Otting N, et al
    The HLA-A03 supertype and several Pan species' MHC-A allotypes share a preference for binding positively charged residues in the F pocket: implications for controlling retroviral infections.
    J Virol. 2020 Feb 19. pii: JVI.01960-19. doi: 10.1128/JVI.01960.
    >> Share

  121. PINZONE MR, Bertuccio MP, VanBelzen DJ, Zurakowski R, et al
    Next Generation Sequencing in a direct model of HIV infection reveals important parallels and differences to in vivo reservoir dynamics.
    J Virol. 2020 Feb 12. pii: JVI.01900-19. doi: 10.1128/JVI.01900.
    >> Share

  122. COGSWELL A, Ferguson N, Barker E
    Presence of Inflammatory Group I and III Innate Lymphoid Cells in the Colon of SIV-infected Rhesus Macaques.
    J Virol. 2020 Feb 12. pii: JVI.01914-19. doi: 10.1128/JVI.01914.
    >> Share

  123. GORNALUSSE GG, Valdez R, Fenkart G, Vojtech L, et al
    Mechanisms of endogenous HIV-1 reactivation by endocervical epithelial cells.
    J Virol. 2020 Feb 12. pii: JVI.01904-19. doi: 10.1128/JVI.01904.
    >> Share

  124. CHEN L, Feng Z, Yuan G, Emerson CC, et al
    HIV-associated exosomes promote infection of Kaposi sarcoma-associated herpesvirus via epidermal growth factor receptor.
    J Virol. 2020 Feb 12. pii: JVI.01782-19. doi: 10.1128/JVI.01782.
    >> Share

  125. MOTA TM, McCann CD, Danesh A, Huang SH, et al
    Integrated assessment of viral transcription, antigen presentation, and CD8+ T cell function reveal multiple limitations of class I selective HDACi during HIV-1 latency reversal.
    J Virol. 2020 Feb 12. pii: JVI.01845-19. doi: 10.1128/JVI.01845.
    >> Share

  126. MILLER CM, Barrett BS, Chen J, Morrison JH, et al
    Systemic Expression of a Viral RdRP Protects Against Retrovirus Infection and Disease.
    J Virol. 2020 Feb 12. pii: JVI.00071-20. doi: 10.1128/JVI.00071.
    >> Share

  127. ISHII H, Terahara K, Nomura T, Takeda A, et al
    A novel immunogen selectively eliciting CD8(+) T cells but not CD4(+) T cells targeting immunodeficiency virus antigens.
    J Virol. 2020 Feb 5. pii: JVI.01876-19. doi: 10.1128/JVI.01876.
    >> Share

    January 2020
  128. ADLAKHA M, Livingston CM, Bezsonova I, Weller SK, et al
    The Herpes Simplex Virus 1 Immediate Early Protein ICP22 Is a Functional Mimic of a Cellular J Protein.
    J Virol. 2020;94.
    >> Share

  129. MELODY K, Roy CN, Kline C, Cottrell ML, et al
    Long-acting rilpivirine (RPV LA) pre-exposure prophylaxis does not inhibit vaginal transmission of RPV-resistant HIV-1 nor select for high frequency drug resistance in humanized mice.
    J Virol. 2020 Jan 22. pii: JVI.01912-19. doi: 10.1128/JVI.01912.
    >> Share

  130. BAUER AM, Ziani W, Lindemuth E, Kuri-Cervantes L, et al
    Novel transmitted/founder SHIVs for HIV latency and cure research.
    J Virol. 2020 Jan 22. pii: JVI.01659-19. doi: 10.1128/JVI.01659.
    >> Share

  131. MIYAGI E, Welbourn S, Sukegawa S, Fabryova H, et al
    Inhibition of Vif-mediated degradation of APOBEC3G through competitive binding of Core-binding factor beta (CBFbeta).
    J Virol. 2020 Jan 15. pii: JVI.01708-19. doi: 10.1128/JVI.01708.
    >> Share

  132. ZURNIC BONISCH I, Dirix L, Lemmens V, Borrenberghs D, et al
    Capsid labelled HIV to investigate the role of capsid during nuclear import and integration.
    J Virol. 2020 Jan 15. pii: JVI.01024-19. doi: 10.1128/JVI.01024.
    >> Share

  133. STONEHAM CA, Ramirez PW, Singh R, Suarez M, et al
    A conserved acidic cluster motif in SERINC5 confers partial resistance to antagonism by HIV-1 Nef.
    J Virol. 2020 Jan 15. pii: JVI.01554-19. doi: 10.1128/JVI.01554.
    >> Share

  134. YANG YR, McCoy LE, van Gils MJ, Andrabi R, et al
    Autologous neutralizing antibody responses to an HIV envelope glycan hole are not easily broadened in rabbits.
    J Virol. 2020 Jan 15. pii: JVI.01861-19. doi: 10.1128/JVI.01861.
    >> Share

  135. PREVOST J, Edgar CR, Richard J, Trothen SM, et al
    HIV-1 Vpu downregulates Tim-3 from the surface of infected CD4(+) T cells.
    J Virol. 2020 Jan 15. pii: JVI.01999-19. doi: 10.1128/JVI.01999.
    >> Share

  136. WANG S, Voronin Y, Zhao P, Ishihara M, et al
    Glycan profiles of gp120 protein vaccines from four major HIV-1 subtypes produced from different host cell lines under non-GMP or GMP conditions.
    J Virol. 2020 Jan 15. pii: JVI.01968-19. doi: 10.1128/JVI.01968.
    >> Share

  137. TAVARES LA, de Carvalho JV, Costa CS, Silveira RM, et al
    Two functional variants of AP-1 complexes composed of either gamma2 or gamma1-subunits are independently required for MHC-I downregulation by HIV-1 Nef.
    J Virol. 2020 Jan 8. pii: JVI.02039-19. doi: 10.1128/JVI.02039.
    >> Share

  138. LE HINGRAT Q, Visseaux B, Bertine M, Chauveau L, et al
    Genetic variability of Long Terminal Repeat region between HIV-2 groups impacts transcriptional activity.
    J Virol. 2020 Jan 8. pii: JVI.01504-19. doi: 10.1128/JVI.01504.
    >> Share

  139. SILVA DE CASTRO I, Gordon SN, Liu J, Bissa M, et al
    Expression of CD40L by the ALVAC-SIV vector abrogates T cell responses in macaques.
    J Virol. 2020 Jan 2. pii: JVI.01933-19. doi: 10.1128/JVI.01933.
    >> Share

  140. EDARA VV, Ghorpade A, Borgmann K
    Insights into the gene expression profiles of active and restricted R/G-HIV+ human astrocytes: Implications for shock or lock therapies in the brain.
    J Virol. 2020 Jan 2. pii: JVI.01563-19. doi: 10.1128/JVI.01563.
    >> Share

    December 2019
  141. RINGE RP, Cruz Portillo VM, Dosenovic P, Ketas TJ, et al
    Neutralizing antibody induction by HIV-1 Envelope glycoprotein SOSIP trimers on iron oxide nanoparticles may be impaired by mannose binding lectin.
    J Virol. 2019 Dec 18. pii: JVI.01883-19. doi: 10.1128/JVI.01883.
    >> Share

  142. STAROPOLI I, Dufloo J, Ducher A, Commere PH, et al
    Flow-cytometry analysis of HIV-1 Env conformations at the surface of infected cells and virions: role of Nef, CD4 and SERINC5.
    J Virol. 2019 Dec 18. pii: JVI.01783-19. doi: 10.1128/JVI.01783.
    >> Share

  143. ROCHE M, Tumpach C, Symons J, Gartner M, et al
    CXCR4-using HIV strains predominate in naive and central memory CD4+ T cells in people living with HIV on antiretroviral therapy: implications for how latency is established and maintained.
    J Virol. 2019 Dec 18. pii: JVI.01736-19. doi: 10.1128/JVI.01736.
    >> Share

  144. KISAKA JK, Ratner L, Kyei GB
    The dual specificity kinase DYRK1A modulates the levels of cyclin L2 to control HIV replication in macrophages.
    J Virol. 2019 Dec 18. pii: JVI.01583-19. doi: 10.1128/JVI.01583.
    >> Share

  145. SOARE AY, Malik HS, Durham ND, Freeman TL, et al
    P2X1 selective antagonists block HIV-1 infection through inhibition of envelope conformation-dependent fusion.
    J Virol. 2019 Dec 18. pii: JVI.01622-19. doi: 10.1128/JVI.01622.
    >> Share

  146. VERMA A, Schmidt BA, Elizaldi SR, Nguyen NK, et al
    Impact of Th1 CD4 TFH skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus Macaques.
    J Virol. 2019 Dec 11. pii: JVI.01737-19. doi: 10.1128/JVI.01737.
    >> Share

  147. ALVES PEIXOTO P, Ferez M, Knudson CJ, Melo-Silva CR, et al
    Loss of resistance to mousepox during chronic lymphocytic choriomeningitis virus infection is associated with impaired T-cell responses and can be rescued by immunization.
    J Virol. 2019 Dec 11. pii: JVI.01832-19. doi: 10.1128/JVI.01832.
    >> Share

  148. KUCHARSKA I, Ding P, Zadrozny KK, Dick RA, et al
    Biochemical reconstitution of HIV-1 assembly and maturation.
    J Virol. 2019 Dec 4. pii: JVI.01844-19. doi: 10.1128/JVI.01844.
    >> Share

  149. DONG J, Liang G, Shang H
    Inhibition of metalloprotease TRABD2A facilitates the study of HIV-1 replication in resting CD4(+) T cells.
    J Virol. 2019 Dec 4. pii: JVI.01655-19. doi: 10.1128/JVI.01655.
    >> Share

  150. WANG V, Davis DA, Deleage C, Brands C, et al
    Induction of Kaposi Sarcoma Associated Herpesvirus-encoded Thymidine Kinase (ORF21) by X-Box Binding Protein-1.
    J Virol. 2019 Dec 4. pii: JVI.01555-19. doi: 10.1128/JVI.01555.
    >> Share

  151. HERNANDEZ MM, Fahrny A, Jayaprakash A, Gers-Huber G, et al
    Impact of suboptimal APOBEC3G neutralization on the emergence of HIV drug resistance in humanized mice.
    J Virol. 2019 Dec 4. pii: JVI.01543-19. doi: 10.1128/JVI.01543.
    >> Share

  152. HUEBER B, Curtis AD 2nd, Kroll K, Varner V, et al
    Functional perturbation of mucosal group 3 innate lymphoid and natural killer cells in SHIV/SIV-infected infant rhesus macaques.
    J Virol. 2019 Dec 4. pii: JVI.01644-19. doi: 10.1128/JVI.01644.
    >> Share

    November 2019
  153. SCHNEIDER JR, Shen X, Orlandi C, Nyanhete T, et al
    A MUC16 IgG binding activity selects for a restricted subset of IgG enriched for certain SIV epitope specificities.
    J Virol. 2019 Nov 27. pii: JVI.01246-19. doi: 10.1128/JVI.01246.
    >> Share

  154. ALVES-PEIXOTO P, Ferez M, Knudson C, Stotesbury C, et al
    Chronic Lymphocytic Choriomeningitis infection causes susceptibility to mousepox and impairs Natural Killer cell maturation and function.
    J Virol. 2019 Nov 27. pii: JVI.01831-19. doi: 10.1128/JVI.01831.
    >> Share

  155. EASTERHOFF D, Pollara J, Luo K, Tolbert WD, et al
    Boosting with AIDSVAX B/E enhances Env constant region 1 and 2 antibody-dependent cellular cytotoxicity breadth and potency.
    J Virol. 2019 Nov 27. pii: JVI.01120-19. doi: 10.1128/JVI.01120.
    >> Share

  156. JONES BR, Miller RL, Kinloch NN, Tsai O, et al
    Genetic diversity, compartmentalization and age of HIV proviruses persisting in CD4+ T cell subsets during long-term combination antiretroviral therapy.
    J Virol. 2019 Nov 27. pii: JVI.01786-19. doi: 10.1128/JVI.01786.
    >> Share

  157. GIBBONS JM, Marno KM, Pike R, Lee WJ, et al
    HIV-1 accessory protein Vpr interacts with REAF/RPRD2 to mitigate its antiviral activity.
    J Virol. 2019 Nov 27. pii: JVI.01591-19. doi: 10.1128/JVI.01591.
    >> Share

  158. ZHANG XL, Luo MT, Song JH, Pang W, et al
    An Alu element insertion into intron 1 results in the aberrant alternative splicing of APOBEC3G pre-mRNA in northern pig-tailed macaques (Macaca leonina) may reduce APOBEC3G-mediated hypermutation pressure on HIV-1.
    J Virol. 2019 Nov 27. pii: JVI.01722-19. doi: 10.1128/JVI.01722.
    >> Share

  159. KATUSIIME MG, Halvas EK, Wright I, Joseph K, et al
    Intact HIV proviruses persist in children 7-9 years after initiation of ART in the first year of life.
    J Virol. 2019 Nov 27. pii: JVI.01519-19. doi: 10.1128/JVI.01519.
    >> Share

  160. FICARELLI M, Antzin-Anduetza I, Hugh-White R, Firth AE, et al
    CpG dinucleotides inhibit HIV-1 replication through zinc finger antiviral protein (ZAP)-dependent and -independent mechanisms.
    J Virol. 2019 Nov 20. pii: JVI.01337-19. doi: 10.1128/JVI.01337.
    >> Share

  161. YANG WS, Lin TY, Chang L, Yeh WW, et al
    HIV-1 Tat Interacts with a Kaposi's Sarcoma-Associated Herpesvirus Reactivation-Upregulated Antiangiogenic Long Noncoding RNA, LINC00313, and Antagonizes Its Function.
    J Virol. 2019 Nov 13. pii: JVI.01280-19. doi: 10.1128/JVI.01280.
    >> Share

  162. LEE E, von Stockenstrom S, Morcilla V, Odevall L, et al
    The impact of antiretroviral therapy duration on the HIV-1 infection of T-cells within anatomic sites.
    J Virol. 2019 Nov 13. pii: JVI.01270-19. doi: 10.1128/JVI.01270.
    >> Share

  163. HENDERSON LJ, Reoma LB, Kovacs JA, Nath A, et al
    Advances towards curing HIV-1 infection from tissue reservoirs.
    J Virol. 2019 Nov 6. pii: JVI.00375-19. doi: 10.1128/JVI.00375.
    >> Share

  164. REGISTRE L, Moreau Y, Toksoz Ataca S, Pulukuri S, et al
    HIV-1 co-receptor usage and variable loop contact impacts V3 loop bnAb susceptibility.
    J Virol. 2019 Nov 6. pii: JVI.01604-19. doi: 10.1128/JVI.01604.
    >> Share

  165. KIBLER KV, Asbach B, Perdiguero B, Garcia-Arriaza J, et al
    Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC".
    J Virol. 2019;93.
    >> Share

    October 2019
  166. YAO W, Yoshida T, Hashimoto S, Takeuchi H, et al
    Vpu of a simian immunodeficiency virus isolated from greater spot-nosed monkey antagonizes human BST-2 via two AxxxxxxxW motifs.
    J Virol. 2019 Oct 30. pii: JVI.01669-19. doi: 10.1128/JVI.01669.
    >> Share

  167. YU F, Li Q, Chen X, Liu J, et al
    X4-tropic Latent HIV-1 is Enriched in Peripheral Follicular Helper T Cells and is Correlated with Disease Progression.
    J Virol. 2019 Oct 30. pii: JVI.01219-19. doi: 10.1128/JVI.01219.
    >> Share

  168. HAHN AS, Bischof GF, Grosskopf AK, Shin YC, et al
    A Recombinant Rhesus Monkey Rhadinovirus Deleted of Glycoprotein L Establishes Persistent Infection of Rhesus Macaques and Elicits Conventional T Cell Responses.
    J Virol. 2019 Oct 23. pii: JVI.01093-19. doi: 10.1128/JVI.01093.
    >> Share

  169. BOPPANA S, Fiore-Gartland A, Bansal A, Goepfert P, et al
    Cross-reactive CD8 T-cell responses elicited by Ad5-based HIV-1 vaccines contributed to early viral evolution in vaccine recipients who became infected.
    J Virol. 2019 Oct 23. pii: JVI.01632-19. doi: 10.1128/JVI.01632.
    >> Share

  170. VAN DORSTEN RT, Lambson BE, Wibmer CK, Weinberg MS, et al
    Neutralization breadth and potency of single-chain variable fragments derived from broadly neutralizing antibodies targeting multiple epitopes on the HIV-1 envelope.
    J Virol. 2019 Oct 16. pii: JVI.01533-19. doi: 10.1128/JVI.01533.
    >> Share

  171. RINGE RP, Colin P, Torres JL, Yasmeen A, et al
    SOS and IP modifications predominantly affect the yield but not other properties of SOSIP.664 HIV-1 Env glycoprotein trimers.
    J Virol. 2019 Oct 16. pii: JVI.01521-19. doi: 10.1128/JVI.01521.
    >> Share

  172. TEDBURY PR, Novikova M, Alfadhli A, Hikichi Y, et al
    HIV-1 matrix trimerization-impaired mutants are rescued by matrix substitutions that enhance envelope glycoprotein incorporation.
    J Virol. 2019 Oct 16. pii: JVI.01526-19. doi: 10.1128/JVI.01526.
    >> Share

  173. ZHU Y, Ding X, Yu D, Chong H, et al
    The Tryptophan-Rich Motif of HIV-1 Gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of Gp41 and Its Inhibitors.
    J Virol. 2019 Oct 16. pii: JVI.01358-19. doi: 10.1128/JVI.01358.
    >> Share

  174. MAVIGNER M, Zanoni M, Tharp GK, Habib J, et al
    Pharmacological modulation of the Wnt/beta-catenin pathway inhibits proliferation and promotes differentiation of long-lived memory CD4(+) T-cells in ART-suppressed SIV-infected macaques.
    J Virol. 2019 Oct 16. pii: JVI.01094-19. doi: 10.1128/JVI.01094.
    >> Share

  175. PASSOS V, Zillinger T, Casartelli N, Wachs AS, et al
    Characterization of Endogenous SERINC5 Protein as anti-HIV-1 Factor.
    J Virol. 2019 Oct 9. pii: JVI.01221-19. doi: 10.1128/JVI.01221.
    >> Share

  176. LONG S, Fennessey CM, Newman L, Reid C, et al
    Evaluating the intactness of persistent viral genomes in SIV-infected rhesus macaques initiating antiretroviral therapy within one year of infection.
    J Virol. 2019 Oct 9. pii: JVI.01308-19. doi: 10.1128/JVI.01308.
    >> Share

  177. MASSANELLA M, Bakeman W, Sithinamsuwan P, Fletcher JLK, et al
    Infrequent HIV infection of circulating monocytes during antiretroviral therapy.
    J Virol. 2019 Oct 9. pii: JVI.01174-19. doi: 10.1128/JVI.01174.
    >> Share

  178. ANANTH S, Morath K, Trautz B, Tibroni N, et al
    Multi-functional roles of the N-terminal region of HIV-1SF2Nef are mediated by three independent protein interaction sites.
    J Virol. 2019 Oct 9. pii: JVI.01398-19. doi: 10.1128/JVI.01398.
    >> Share

  179. KHANAL S, Fennessey CM, O'Brien SP, Thorpe A, et al
    In vivo validation of the viral barcoding of SIVmac239 and the development of new barcoded SIV and subtype B and C SHIVs.
    J Virol. 2019 Oct 9. pii: JVI.01420-19. doi: 10.1128/JVI.01420.
    >> Share

  180. BOHN JA, DaSilva J, Kharytonchyk S, Mercedes M, et al
    Flexibility in nucleic acid binding is central to APOBEC3H antiviral activity.
    J Virol. 2019 Oct 2. pii: JVI.01275-19. doi: 10.1128/JVI.01275.
    >> Share

  181. LUO X, Herzig E, Doitsh G, Grimmett ZW, et al
    HIV-2 depletes CD4 T cells through pyroptosis despite Vpx-dependent degradation of SAMHD1.
    J Virol. 2019 Oct 2. pii: JVI.00666-19. doi: 10.1128/JVI.00666.
    >> Share

  182. BUFFALO CZ, Iwamoto Y, Hurley JH, Ren X, et al
    How HIV Nef Proteins Hijack Membrane Traffic to Promote Infection.
    J Virol. 2019 Oct 2. pii: JVI.01322-19. doi: 10.1128/JVI.01322.
    >> Share

  183. KULPA DA, Talla A, Brehm JH, Ribeiro SP, et al
    Differentiation to an effector memory phenotype potentiates HIV-l latency reversal in CD4+ T cells.
    J Virol. 2019 Oct 2. pii: JVI.00969-19. doi: 10.1128/JVI.00969.
    >> Share

    September 2019
  184. FERNANDEZ MV, Delviks-Frankenberry KA, Scheiblin DA, Happel C, et al
    Authentication analysis of MT-4 cells distributed by the NIH AIDS Reagent Program.
    J Virol. 2019 Sep 25. pii: JVI.01390-19. doi: 10.1128/JVI.01390.
    >> Share

  185. DING S, Grenier MC, Tolbert WD, Vezina D, et al
    A new family of small-molecule CD4-mimetic compounds contact the highly conserved aspartic acid 368 of HIV-1 gp120 and mediates ADCC.
    J Virol. 2019 Sep 25. pii: JVI.01325-19. doi: 10.1128/JVI.01325.
    >> Share

  186. CHENG AZ, Nobrega de Moraes S, Attarian C, Yockteng-Melgar J, et al
    A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
    J Virol. 2019 Sep 18. pii: JVI.01539-19. doi: 10.1128/JVI.01539.
    >> Share

  187. KIANI Z, Dupuy FP, Bruneau J, Lebouche B, et al
    The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.
    J Virol. 2019 Sep 11. pii: JVI.01185-19. doi: 10.1128/JVI.01185.
    >> Share

  188. SULTANA T, Mamede JI, Saito A, Ode H, et al
    Multiple pathways to avoid IFN-beta sensitivity of HIV-1 by mutations in capsid.
    J Virol. 2019 Sep 11. pii: JVI.00986-19. doi: 10.1128/JVI.00986.
    >> Share

  189. THORNHILL D, Olety B, Ono A
    Relationships between MA-RNA binding in cells and suppression of HIV-1 Gag mislocalization to intracellular membranes.
    J Virol. 2019 Sep 11. pii: JVI.00756-19. doi: 10.1128/JVI.00756.
    >> Share

  190. DING S, Gasser R, Gendron-Lepage G, Medjahed H, et al
    CD4 Incorporation into HIV-1 Viral Particles Exposes Envelope Epitopes Recognized by CD4-induced Antibodies.
    J Virol. 2019 Sep 4. pii: JVI.01403-19. doi: 10.1128/JVI.01403.
    >> Share

    August 2019
  191. TANG X, Jin H, Chen Y, Li L, et al
    A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of HIV-1, HIV-2, and Simian Immunodeficiency Virus.
    J Virol. 2019 Aug 28. pii: JVI.01177-19. doi: 10.1128/JVI.01177.
    >> Share

  192. SLIVA K, Martin J, von Rhein C, Herrmann T, et al
    Interference with SAMHD1 restores late gene expression of modified vaccinia virus Ankara (MVA) in human dendritic cells and abrogates type I interferon expression.
    J Virol. 2019 Aug 28. pii: JVI.01097-19. doi: 10.1128/JVI.01097.
    >> Share

  193. LI SS, Gilbert PB, Carpp LN, Pyo CW, et al
    Fc gamma receptor polymorphisms modulated the vaccine effect on HIV-1 risk in the HVTN 505 HIV vaccine trial.
    J Virol. 2019 Aug 21. pii: JVI.02041-18. doi: 10.1128/JVI.02041.
    >> Share

  194. AFFRAM Y, Zapata JC, Gholizadeh Z, Tolbert WD, et al
    The HIV-1 antisense protein ASP is a transmembrane protein of the cell surface and an integral protein of the HIV-1 viral envelope.
    J Virol. 2019 Aug 21. pii: JVI.00574-19. doi: 10.1128/JVI.00574.
    >> Share

  195. KUTLUAY SB, Emery A, Penumutchu S, Townsend D, et al
    Genome wide analysis of hnRNP binding to HIV-1 RNA reveals a key role for hnRNP H1 in alternative viral mRNA splicing.
    J Virol. 2019 Aug 14. pii: JVI.01048-19. doi: 10.1128/JVI.01048.
    >> Share

  196. ALMOND N, Berry N, Stebbings R, Preston M, et al
    Vaccination of macaques with DNA followed by adenoviral vectors encoding SIV gag alone delays infection by repeated mucosal challenge with SIV.
    J Virol. 2019 Aug 14. pii: JVI.00606-19. doi: 10.1128/JVI.00606.
    >> Share

  197. PALERMO E, Acchioni C, Di Carlo D, Zevini A, et al
    Activation of latent HIV-1 T cell reservoirs with a combination of innate immune and epigenetic regulators.
    J Virol. 2019 Aug 14. pii: JVI.01194-19. doi: 10.1128/JVI.01194.
    >> Share

  198. ANDERSON-DANIELS J, Singh PK, Sowd GA, Li W, et al
    Dominant negative MA-CA fusion protein is incorporated into HIV-1 cores and inhibits nuclear entry of viral preintegration complexes.
    J Virol. 2019 Aug 14. pii: JVI.01118-19. doi: 10.1128/JVI.01118.
    >> Share

  199. ZHAO C, Princiotto AM, Nguyen HT, Zou S, et al
    Strain-dependent Activation and Inhibition of Human Immunodeficiency Virus (HIV-1) Entry by a Specific PF-68742 Stereoisomer.
    J Virol. 2019 Aug 7. pii: JVI.01197-19. doi: 10.1128/JVI.01197.
    >> Share

  200. DU C, Duan Y, Wang X, Lin Y, et al
    Attenuation of equine lentivirus alters mitochondrial protein expression profile from inflammation to apoptosis.
    J Virol. 2019 Aug 7. pii: JVI.00653-19. doi: 10.1128/JVI.00653.
    >> Share

  201. ALFADHLI A, Staubus AO, Tedbury PR, Novikova M, et al
    Analysis of HIV-1 matrix-envelope cytoplasmic tail interactions.
    J Virol. 2019 Aug 2. pii: JVI.01079-19. doi: 10.1128/JVI.01079.
    >> Share

  202. WU Y, Xue J, Wang C, Li W, et al
    Rapid elimination of broadly neutralizing antibodies correlates with treatment failure in the acute phase of SHIV infection.
    J Virol. 2019 Aug 2. pii: JVI.01077-19. doi: 10.1128/JVI.01077.
    >> Share

  203. GACH JS, Mara KJV, LaBranche CC, van Gils MJ, et al
    Antibody responses elicited by immunization with BG505 trimer-immune complexes.
    J Virol. 2019 Aug 2. pii: JVI.01188-19. doi: 10.1128/JVI.01188.
    >> Share

  204. WENSEL D, Sun Y, Davis J, Li Z, et al
    GSK3732394: A multi-specific inhibitor of HIV entry.
    J Virol. 2019 Aug 2. pii: JVI.00907-19. doi: 10.1128/JVI.00907.
    >> Share

  205. CLAIBORNE DT, Dudek TE, Maldini CR, Power KA, et al
    Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia.
    J Virol. 2019 Aug 2. pii: JVI.00814-19. doi: 10.1128/JVI.00814.
    >> Share

  206. RIHN SJ, Aziz MA, Stewart DG, Hughes J, et al
    TRIM69 inhibits Vesicular Stomatitis Indiana Virus (VSIV).
    J Virol. 2019 Aug 2. pii: JVI.00951-19. doi: 10.1128/JVI.00951.
    >> Share

  207. THANS TVS, Akko JI, Niehrs A, Garcia-Beltran WF, et al
    Primary HIV-1 strains use Nef to downmodulate HLA-E surface expression.
    J Virol. 2019 Aug 2. pii: JVI.00719-19. doi: 10.1128/JVI.00719.
    >> Share

    July 2019
  208. BOCHNAKIAN A, Zhen A, Zisoulis DG, Idica A, et al
    Interferon-inducible miR-128 modulates HIV-1 replication by targeting TNPO3 mRNA.
    J Virol. 2019 Jul 24. pii: JVI.00364-19. doi: 10.1128/JVI.00364.
    >> Share

  209. STYLES TM, Gangadhara S, Reddy PBJ, Hicks S, et al
    HIV C.1086 Envelope Gp140 Protein Boosts Following DNA/MVA Vaccination Fail to Enhance Heterologous Anti-V1V2 Antibody Response and Protection Against Clade C SHIV Challenge.
    J Virol. 2019 Jul 24. pii: JVI.00934-19. doi: 10.1128/JVI.00934.
    >> Share

  210. QIAN W, Miner CA, Ingle H, Platt DJ, et al
    A human STAT1 gain-of-function mutation impairs CD8(+) T cell responses against gammaherpesvirus-68.
    J Virol. 2019 Jul 17. pii: JVI.00307-19. doi: 10.1128/JVI.00307.
    >> Share

  211. YERO A, Farnos O, Rabezanahary H, Racine G, et al
    Differential dynamics of regulatory T-cell (Treg) and Th17 cell balance in mesenteric lymph nodes and blood following early anti-retroviral initiation during acute SIV infection.
    J Virol. 2019 Jul 17. pii: JVI.00371-19. doi: 10.1128/JVI.00371.
    >> Share

  212. LOPEZ P, Koh WH, Hnatiuk R, Murooka TT, et al
    HIV infection stabilizes macrophage:T cell interactions to promote cell-cell HIV spread.
    J Virol. 2019 Jul 3. pii: JVI.00805-19. doi: 10.1128/JVI.00805.
    >> Share

  213. ORTIZ AM, Flynn JK, DiNapoli SR, Sortino O, et al
    Antiretroviral therapy administration in healthy rhesus macaques is associated with transient shifts in intestinal bacterial diversity and modest immunological perturbations.
    J Virol. 2019 Jul 3. pii: JVI.00472-19. doi: 10.1128/JVI.00472.
    >> Share

  214. KIANI Z, Bruneau J, Geraghty DE, Bernard NF, et al
    HLA-F on autologous HIV infected cells activates primary NK cells expressing the activating killer immunoglobulin-like receptor KIR3DS1.
    J Virol. 2019 Jul 3. pii: JVI.00933-19. doi: 10.1128/JVI.00933.
    >> Share

    June 2019
  215. ACCHIONI C, Remoli AL, Marsili G, Acchioni M, et al
    Alternate NF-kappaB independent signaling re-activation of latent HIV-1 provirus.
    J Virol. 2019 Jun 26. pii: JVI.00495-19. doi: 10.1128/JVI.00495.
    >> Share

  216. FARR ZUEND C, Nomellini JF, Smit J, Horwitz MS, et al
    A Caulobacter crescentus microbicide protects from vaginal infection with HIV-1JR-CSF in Humanized Bone Marrow-Liver-Thymus Mice.
    J Virol. 2019 Jun 26. pii: JVI.00614-19. doi: 10.1128/JVI.00614.
    >> Share

  217. BAR KJ, Coronado E, Hensley-McBain T, O'Connor MA, et al
    SHIV.CH505 infection of rhesus macaques results in persistent viral replication and induces intestinal immunopathology.
    J Virol. 2019 Jun 19. pii: JVI.00372-19. doi: 10.1128/JVI.00372.
    >> Share

  218. SOJAR H, Baron S, Sullivan JT, Garrett M, et al
    Monoclonal antibody 2C6 targets cross-clade conformational epitope in gp41 with highly active antibody dependent cell cytotoxicity.
    J Virol. 2019 Jun 19. pii: JVI.00772-19. doi: 10.1128/JVI.00772.
    >> Share

  219. CHIKATA T, Paes W, Akahoshi T, Partridge T, et al
    Identification of immunodominant HIV-1 epitopes presented by HLA-C*12:02, a protective allele, using an immunopeptidomics approach.
    J Virol. 2019 Jun 19. pii: JVI.00634-19. doi: 10.1128/JVI.00634.
    >> Share

  220. MISHRA N, Makhdoomi MA, Sharma S, Kumar S, et al
    Viral characteristics associated with maintenance of elite neutralizing activity in chronically HIV-1 clade C infected monozygotic pediatric twins.
    J Virol. 2019 Jun 19. pii: JVI.00654-19. doi: 10.1128/JVI.00654.
    >> Share

  221. MILLER RL, Ponte R, Jones BR, Kinloch NN, et al
    HIV diversity and genetic compartmentalization in blood and testes during suppressive antiretroviral therapy.
    J Virol. 2019 Jun 12. pii: JVI.00755-19. doi: 10.1128/JVI.00755.
    >> Share

  222. ZOLLA-PAZNER S, Gilbert PB
    REVISITING THE CORRELATE OF REDUCED HIV INFECTION RISK IN THE RV144 VACCINE TRIAL.
    J Virol. 2019 Jun 12. pii: JVI.00629-19. doi: 10.1128/JVI.00629.
    >> Share

  223. KOMA T, Kotani O, Miyakawa K, Ryo A, et al
    Allosteric regulation of HIV-1 capsid structure for Gag assembly, virion production, and viral infectivity by a disordered interdomain linker.
    J Virol. 2019 Jun 12. pii: JVI.00381-19. doi: 10.1128/JVI.00381.
    >> Share

  224. SIDDIQUI MA, Saito A, Halambage UD, Ferhadian D, et al
    A novel phenotype links HIV-1 capsid stability to cGAS-mediated DNA sensing.
    J Virol. 2019 Jun 5. pii: JVI.00706-19. doi: 10.1128/JVI.00706.
    >> Share

  225. KRAKOFF E, Gagne RB, VandeWoude S, Carver S, et al
    Variation in intra-individual lentiviral evolution rates: A systematic review of human, non-human primate and felid species.
    J Virol. 2019 Jun 5. pii: JVI.00538-19. doi: 10.1128/JVI.00538.
    >> Share

  226. RAM DR, Lucar O, Hueber B, Reeves RK, et al
    SIV infection modulates CD94 (KLRD1)+ NK cells in rhesus macaques.
    J Virol. 2019 Jun 5. pii: JVI.00731-19. doi: 10.1128/JVI.00731.
    >> Share

  227. KHAN SN, Sok D, Tran K, Movsesyan A, et al
    Correction for Khan et al., "Targeting the HIV-1 Spike and Coreceptor with Bi- and Trispecific Antibodies for Single-Component Broad Inhibition of Entry".
    J Virol. 2019;93.
    >> Share

    May 2019
  228. ABREU CM, Veenhuis RT, Avalos CR, Graham S, et al
    Infectious virus persists in CD4+ T cells and macrophages in ART-suppressed SIV-infected Macaques.
    J Virol. 2019 May 22. pii: JVI.00065-19. doi: 10.1128/JVI.00065.
    >> Share

  229. VALDEZ F, Salvador J, Palermo PM, Mohl JE, et al
    Schlafen 11 Restricts Flavivirus Replication.
    J Virol. 2019 May 22. pii: JVI.00104-19. doi: 10.1128/JVI.00104.
    >> Share

  230. NELSON AN, Goswami R, Dennis M, Tu J, et al
    SHIV.CH505-infected infant and adult rhesus macaques exhibit similar HIV Env-specific antibody kinetics, despite distinct T-follicular helper (Tfh) and germinal center B cell landscapes.
    J Virol. 2019 May 15. pii: JVI.00168-19. doi: 10.1128/JVI.00168.
    >> Share

  231. SINGLETON CD, Humby MS, Yi HA, Rizzo RC, et al
    Identification of Ebola Virus Inhibitors Targeting GP2 using Principles of Molecular Mimicry.
    J Virol. 2019 May 15. pii: JVI.00676-19. doi: 10.1128/JVI.00676.
    >> Share

  232. FELLINGER CH, Gardner MR, Weber JA, Alfant B, et al
    eCD4-Ig limits HIV-1 escape more effectively than CD4-Ig or a broadly neutralizing antibody.
    J Virol. 2019 May 8. pii: JVI.00443-19. doi: 10.1128/JVI.00443.
    >> Share

  233. IMAM S, Komurlu S, Mattick J, Selyutina A, et al
    K63-linked Ubiquitin is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus Trim5alpha.
    J Virol. 2019 May 8. pii: JVI.00558-19. doi: 10.1128/JVI.00558.
    >> Share

  234. JONES DI, Pollara JJ, Johnson-Weaver BT, LaBranche CC, et al
    Optimized Mucosal MVA Prime/Soluble gp120 Boost Vaccination Regimen Induces Similar Antibody Responses as an Intramuscular Regimen.
    J Virol. 2019 May 8. pii: JVI.00475-19. doi: 10.1128/JVI.00475.
    >> Share

  235. PUSNIK J, Eller MA, Tassaneetrithep B, Schultz BT, et al
    Expansion of stem-cell-like CD4(+) memory T cells during acute HIV-1 infection is linked to rapid disease progression.
    J Virol. 2019 May 1. pii: JVI.00377-19. doi: 10.1128/JVI.00377.
    >> Share

  236. ZHANG X, Shi J, Qiu X, Chai Q, et al
    CD4 expression and Env conformation are critical for HIV-1 restriction by SERINC5.
    J Virol. 2019 May 1. pii: JVI.00544-19. doi: 10.1128/JVI.00544.
    >> Share

    April 2019
  237. CHRISTENSEN-QUICK A, Massanella M, Frick A, Rawlings SA, et al
    Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
    J Virol. 2019 Apr 24. pii: JVI.00179-19. doi: 10.1128/JVI.00179.
    >> Share

  238. WILLIAMS-WIETZIKOSKI CA, Campbell MS, Payant R, Lam A, et al
    Comparisons of human immunodeficiency virus type 1 envelope variants in blood and genital fluids near the time of male-to-female transmission.
    J Virol. 2019 Apr 17. pii: JVI.01769-18. doi: 10.1128/JVI.01769.
    >> Share

  239. LI G, Zhang Z, Reszka-Blanco N, Li F, et al
    Specific activation of HIV-1 by a bromodomain inhibitor from monocytic cells in humanized mice under ART in vivo.
    J Virol. 2019 Apr 10. pii: JVI.00233-19. doi: 10.1128/JVI.00233.
    >> Share

  240. NGUYEN HT, Alsahafi N, Finzi A, Sodroski JG, et al
    Effects of the SOS (A501C/T605C) and DS (I201C/A433C) Disulfide Bonds on HIV-1 Membrane Envelope Glycoprotein Conformation and Function.
    J Virol. 2019 Apr 3. pii: JVI.00304-19. doi: 10.1128/JVI.00304.
    >> Share

  241. HANKE K, Faria NR, Kuhnert D, Pouran Yousef K, et al
    Reconstruction of the genetic history and the current spread of HIV-1 subtype A in Germany.
    J Virol. 2019 Apr 3. pii: JVI.02238-18. doi: 10.1128/JVI.02238.
    >> Share

    March 2019
  242. TAKATA H, Kessing C, Sy A, Lima N, et al
    Modeling HIV-1 latency using primary CD4(+) T cells from HIV-1 infected ART suppressed individuals.
    J Virol. 2019 Mar 27. pii: JVI.02248-18. doi: 10.1128/JVI.02248.
    >> Share

  243. RAWLE DJ, Li D, Wu Z, Wang L, et al
    Oxazole-benzenesulfonamide derivatives inhibit HIV-1 reverse transcriptase interaction with cellular eEF1A and reduce viral replication.
    J Virol. 2019 Mar 27. pii: JVI.00239-19. doi: 10.1128/JVI.00239.
    >> Share

  244. LAMBERT C, Batalie D, Montange T, Betsem E, et al
    An immunodominant and conserved B-cell epitope in the envelope of simian foamy virus recognized by humans infected with zoonotic strains from apes.
    J Virol. 2019 Mar 20. pii: JVI.00068-19. doi: 10.1128/JVI.00068.
    >> Share

  245. HEREDIA JD, Park J, Choi H, Gill KS, et al
    Conformational engineering of HIV-1 Env based on mutational tolerance in the CD4 and PG16 bound states.
    J Virol. 2019 Mar 20. pii: JVI.00219-19. doi: 10.1128/JVI.00219.
    >> Share

  246. ANAND SP, Grover JR, Tolbert WD, Prevost J, et al
    Antibody-induced internalization of HIV-1 Env proteins limits the surface expression of the closed conformation of Env.
    J Virol. 2019 Mar 20. pii: JVI.00293-19. doi: 10.1128/JVI.00293.
    >> Share

  247. ZHUANG M, Vassell R, Yuan C, Keller PW, et al
    Mutations that increase the stability of the post-fusion gp41 conformation of the HIV-1 envelope glycoprotein are selected by both an X4 and R5 HIV-1 virus to escape fusion inhibitors corresponding to heptad repeat 1 of gp41, but the gp120 adaptive mu
    J Virol. 2019 Mar 20. pii: JVI.00142-19. doi: 10.1128/JVI.00142.
    >> Share

  248. BOYER PL, Melody K, Smith SJ, Dunn LL, et al
    Two Co-Selected Distal Mutations in HIV-1 Reverse Transcriptase (RT) Alter Susceptibility to Non-nucleoside RT Inhibitors and Nucleoside Analogs.
    J Virol. 2019 Mar 20. pii: JVI.00224-19. doi: 10.1128/JVI.00224.
    >> Share

  249. SONG YE, Olinger GY, Janaka SK, Johnson MC, et al
    Sequence determinants in gammaretroviral Env cytoplasmic tails dictate virus-specific pseudotyping compatibility.
    J Virol. 2019 Mar 20. pii: JVI.02172-18. doi: 10.1128/JVI.02172.
    >> Share

  250. LEYMARIE O, Lepont L, Versapuech M, Judith D, et al
    Contribution of the cytoplasmic determinants of Vpu to the expansion of virus containing compartments in HIV-1 infected macrophages.
    J Virol. 2019 Mar 13. pii: JVI.00020-19. doi: 10.1128/JVI.00020.
    >> Share

  251. SKELTON JK, Ortega-Prieto AM, Kaye S, Jimenez-Guardeno JM, et al
    Kinetics of early innate immune activation during HIV-1 infection of humanized mice.
    J Virol. 2019 Mar 13. pii: JVI.02123-18. doi: 10.1128/JVI.02123.
    >> Share

  252. SHARMA S, Jafari M, Bangar A, William K, et al
    The C-terminal end of HIV-1 viral protein U (Vpu) encodes a clade-specific determinant to antagonize BST-2 and facilitate virion release.
    J Virol. 2019 Mar 13. pii: JVI.02315-18. doi: 10.1128/JVI.02315.
    >> Share

  253. JUNO JA, Wragg KM, Kristensen AB, Lee WS, et al
    Modulation of the CCR5 receptor/ligand axis by seminal plasma and the utility of in vitro versus in vivo models.
    J Virol. 2019 Mar 13. pii: JVI.00242-19. doi: 10.1128/JVI.00242.
    >> Share

  254. ZHU Y, Chong H, Yu D, Guo Y, et al
    Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity.
    J Virol. 2019 Mar 13. pii: JVI.02312-18. doi: 10.1128/JVI.02312.
    >> Share

  255. SHERPA C, Jackson PEH, Gray LR, Anastos K, et al
    Evolution of the HIV-1 RRE during natural infection reveals nucleotide changes that correlate with altered structure and increased activity over time.
    J Virol. 2019 Mar 13. pii: JVI.02102-18. doi: 10.1128/JVI.02102.
    >> Share

  256. LLEWELLYN GN, Seclen E, Wietgrefe S, Liu S, et al
    A humanized mouse model of HIV-1 latency with enrichment of latent virus in PD-1+ and TIGIT+ CD4 T cells.
    J Virol. 2019 Mar 6. pii: JVI.02086-18. doi: 10.1128/JVI.02086.
    >> Share

  257. LI X, Huang L, Xiao Y, Yao X, et al
    Development of an ORF45-derived peptide to inhibit the sustained RSK activation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
    J Virol. 2019 Mar 6. pii: JVI.02154-18. doi: 10.1128/JVI.02154.
    >> Share

  258. POLLARA J, Jones DI, Huffman T, Edwards RW, et al
    Bridging vaccine-induced HIV-1 neutralizing and effector antibody responses in rabbit and rhesus macaque animal models.
    J Virol. 2019 Mar 6. pii: JVI.02119-18. doi: 10.1128/JVI.02119.
    >> Share

  259. LEE WS, Prevost J, Richard J, van der Sluis RM, et al
    CD4- and time-dependent susceptibility of HIV-1-infected cells to ADCC.
    J Virol. 2019 Mar 6. pii: JVI.01901-18. doi: 10.1128/JVI.01901.
    >> Share

  260. MABVAKURE BM, Lambson BE, Ramdayal K, Masson L, et al
    Evidence for both intermittent and persistent compartmentalization of HIV-1 in the female genital tract.
    J Virol. 2019 Mar 6. pii: JVI.00311-19. doi: 10.1128/JVI.00311.
    >> Share

  261. SILVER ZA, Dickinson GM, Seaman MS, Desrosiers RC, et al
    A highly unusual V1 region of Env in an elite controller of HIV infection.
    J Virol. 2019 Mar 6. pii: JVI.00094-19. doi: 10.1128/JVI.00094.
    >> Share

  262. MATCHETT WE, Anguiano-Zarate SS, Nehete PN, Shelton K, et al
    Divergent HIV-1 Directed Immune Responses Generated by Systemic and Mucosal Immunization with Replicating Single-Cycle Adenoviruses in Rhesus Macaques.
    J Virol. 2019 Mar 6. pii: JVI.02016-18. doi: 10.1128/JVI.02016.
    >> Share

    February 2019
  263. HOCINI H, Bonnabau H, Lacabaratz C, Lefebvre C, et al
    HIV controllers have low inflammation associated with a strong HIV-specific immune response in blood.
    J Virol. 2019 Feb 27. pii: JVI.01690-18. doi: 10.1128/JVI.01690.
    >> Share

  264. FISCHER DK, Saito A, Kline C, Cohen R, et al
    CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes.
    J Virol. 2019 Feb 27. pii: JVI.00214-19. doi: 10.1128/JVI.00214.
    >> Share

  265. WU E, Du Y, Gao X, Zhang J, et al
    V1 and V2 Domains of HIV Envelope Contribute to CCR5 Antagonist Resistance.
    J Virol. 2019 Feb 20. pii: JVI.00050-19. doi: 10.1128/JVI.00050.
    >> Share

  266. LAI S, Starke CE, Flynn JK, Vinton CL, et al
    SIV infects functionally polarized memory CD4 T cells equivalently in vivo.
    J Virol. 2019 Feb 20. pii: JVI.02163-18. doi: 10.1128/JVI.02163.
    >> Share

  267. VAN DOMSELAAR R, Njenda DT, Rao R, Sonnerborg A, et al
    HIV-1 subtype C with PYxE insertion has enhanced binding of Gag-p6 to host cell protein ALIX and increased replication fitness.
    J Virol. 2019 Feb 13. pii: JVI.00077-19. doi: 10.1128/JVI.00077.
    >> Share

  268. VAN DIEPEN MT, Chapman R, Douglass N, Galant S, et al
    Prime boost immunisations with DNA, MVA and protein-based vaccines elicit robust HIV-1, Tier 2 neutralizing antibodies against the CAP256 superinfecting virus.
    J Virol. 2019 Feb 13. pii: JVI.02155-18. doi: 10.1128/JVI.02155.
    >> Share

  269. ZHOU M, Humbert M, Mukhtar MM, Scinto HB, et al
    Adaptation of an R5 Simian-human Immunodeficiency Virus Encoding an HIV Clade A Envelope With or Without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.
    J Virol. 2019 Feb 13. pii: JVI.02267-18. doi: 10.1128/JVI.02267.
    >> Share

  270. WEI W, Wiggins J, Hu D, Vrbanac V, et al
    Blocking HIV-1 infection by chromosomal integrative expression of human CD4 on the surface of Lactobacillus helveticus R0052.
    J Virol. 2019 Feb 6. pii: JVI.01830-18. doi: 10.1128/JVI.01830.
    >> Share

  271. BANG BR, Li M, Tsai KN, Aoyagi H, et al
    Regulation of HCV infection by Cellular Retinoic Acid Binding Proteins through the modulation of lipid droplet abundance.
    J Virol. 2019 Feb 6. pii: JVI.02302-18. doi: 10.1128/JVI.02302.
    >> Share

  272. UPPAL T, Meyer D, Agrawal A, Verma SC, et al
    The DNase Activity of KSHV SOX Protein Serves an Important Role in Viral Genome Processing During Lytic Replication.
    J Virol. 2019 Feb 6. pii: JVI.01983-18. doi: 10.1128/JVI.01983.
    >> Share

  273. OJWACH DBA, MacMillan D, Reddy T, Novitsky V, et al
    Correction for Ojwach et al., "Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection".
    J Virol. 2019;93.
    >> Share

    January 2019
  274. POHLMEYER CW, Gonzalez VD, Irrinki A, Ramirez RN, et al
    Identification of NK cell subpopulations that differentiate HIV-infected subject cohorts with diverse level of virus control.
    J Virol. 2019 Jan 30. pii: JVI.01790-18. doi: 10.1128/JVI.01790.
    >> Share

  275. TAY MZ, Kunz EL, Deal A, Zhang L, et al
    Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in HIV-1 Chronically Infected Women.
    J Virol. 2019 Jan 30. pii: JVI.02084-18. doi: 10.1128/JVI.02084.
    >> Share

  276. VIBHOLM LK, Lorenzi JCC, Pai JA, Cohen YZ, et al
    Characterization of intact proviruses in blood and lymph node from HIV-infected individuals undergoing analytical treatment interruption.
    J Virol. 2019 Jan 30. pii: JVI.01920-18. doi: 10.1128/JVI.01920.
    >> Share

  277. MAYBERRY CL, Soucy AN, Lajoie CR, DuShane JK, et al
    JC Polyomavirus Entry by Clathrin-Mediated Endocytosis is Driven by beta-arrestin.
    J Virol. 2019 Jan 30. pii: JVI.01948-18. doi: 10.1128/JVI.01948.
    >> Share

  278. YU J, Liang C, Liu SL
    CD4-dependent Modulation of HIV-1 Entry by LY6E.
    J Virol. 2019 Jan 23. pii: JVI.01866-18. doi: 10.1128/JVI.01866.
    >> Share

  279. BRETON Y, Desrosiers V, Ouellet M, Deshiere A, et al
    Expression of MDM2 in macrophages promotes the early post-entry steps of HIV-1 infection through inhibition of p53.
    J Virol. 2019 Jan 23. pii: JVI.01871-18. doi: 10.1128/JVI.01871.
    >> Share

  280. ZOU C, Murakoshi H, Kuse N, Akahoshi T, et al
    Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
    J Virol. 2019 Jan 23. pii: JVI.02142-18. doi: 10.1128/JVI.02142.
    >> Share

  281. LU W, Chen S, Yu J, Behrens R, et al
    The Polar Region of HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing gp120-gp41 Association.
    J Virol. 2019 Jan 16. pii: JVI.02128-18. doi: 10.1128/JVI.02128.
    >> Share

  282. TSO FY, West JT, Wood C
    Reduction of Kaposi's sarcoma-associated herpesvirus latency using CRISPR-Cas9 to edit the latency-associated nuclear antigen gene.
    J Virol. 2019 Jan 16. pii: JVI.02183-18. doi: 10.1128/JVI.02183.
    >> Share

  283. BURTON S, Spicer LM, Charles TP, Gangadhara S, et al
    Clade C HIV-1 envelope vaccination regimens differ in their ability to elicit antibodies with moderate neutralization breadth against genetically diverse tier 2 HIV-1 envelope variants.
    J Virol. 2019 Jan 16. pii: JVI.01846-18. doi: 10.1128/JVI.01846.
    >> Share

  284. FLERIN NC, Bardhi A, Zheng JH, Korom M, et al
    Establishment of A Novel Humanized Mouse Model To Investigate In Vivo Activation and Depletion of Patient-Derived HIV Latent Reservoirs.
    J Virol. 2019 Jan 9. pii: JVI.02051-18. doi: 10.1128/JVI.02051.
    >> Share

  285. LIPPOLD S, Braun B, Kruger F, Harms M, et al
    Natural inhibitor of human cytomegalovirus in human seminal plasma.
    J Virol. 2019 Jan 9. pii: JVI.01855-18. doi: 10.1128/JVI.01855.
    >> Share

  286. OMONDI FH, Chandrarathna S, Mujib S, Brumme CJ, et al
    HIV subtype and Nef-mediated immune evasion function correlate with viral reservoir size in early-treated individuals.
    J Virol. 2019 Jan 2. pii: JVI.01832-18. doi: 10.1128/JVI.01832.
    >> Share

    December 2018
  287. MABVAKURE BM, Scheepers C, Garrett N, Abdool Karim S, et al
    Positive selection at key residues in the HIV Envelope distinguishes broad and strain-specific plasma neutralizing antibodies.
    J Virol. 2018 Dec 19. pii: JVI.01685-18. doi: 10.1128/JVI.01685.
    >> Share

  288. BOUVIN-PLEY M, Beretta M, Moreau A, Roch E, et al
    Evolution of the Envelope Glycoprotein of HIV-1 Clade B towards Higher Infectious Properties over the Course of the Epidemic.
    J Virol. 2018 Dec 19. pii: JVI.01171-18. doi: 10.1128/JVI.01171.
    >> Share

  289. BALASUBRAMANIAM M, Zhou J, Addai A, Martinez P, et al
    PF74 Inhibits HIV-1 Integration by Altering The Composition of the Preintegration Complex.
    J Virol. 2018 Dec 19. pii: JVI.01741-18. doi: 10.1128/JVI.01741.
    >> Share

  290. URANO E, Timilsina U, Kaplan JA, Ablan S, et al
    RESISTANCE TO SECOND-GENERATION HIV-1 MATURATION INHIBITORS.
    J Virol. 2018 Dec 19. pii: JVI.02017-18. doi: 10.1128/JVI.02017.
    >> Share

  291. UNGERLEIDER N, Jain V, Wang Y, Maness NJ, et al
    Comparative analysis of gammaherpesvirus circRNA repertoires: conserved and unique viral circRNAs.
    J Virol. 2018 Dec 19. pii: JVI.01952-18. doi: 10.1128/JVI.01952.
    >> Share

  292. MARTINS MA, Gonzalez-Nieto L, Shin YC, Domingues A, et al
    Vaccine-induced T-cell responses do not predict the rate of acquisition after repeated intrarectal SIVmac239 challenges in Mamu-B*08+ rhesus macaques.
    J Virol. 2018 Dec 12. pii: JVI.01626-18. doi: 10.1128/JVI.01626.
    >> Share

  293. AMELIO P, Portevin D, Hella J, Reither K, et al
    HIV Infection Functionally Impairs Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses.
    J Virol. 2018 Dec 12. pii: JVI.01728-18. doi: 10.1128/JVI.01728.
    >> Share

  294. DENNIS M, Eudailey J, Pollara J, McMillan AS, et al
    Co-administration of CH31 broadly neutralizing antibody does not affect development of vaccine-induced anti-HIV-1 envelope antibody responses in infant Rhesus macaques.
    J Virol. 2018 Dec 12. pii: JVI.01783-18. doi: 10.1128/JVI.01783.
    >> Share

  295. GARCIA-BATES TM, Palma ML, Shen C, Gambotto A, et al
    Contrasting roles of the PD-1 signaling pathway in dendritic cell-mediated induction and regulation of HIV-1-specific effector T cell functions.
    J Virol. 2018 Dec 12. pii: JVI.02035-18. doi: 10.1128/JVI.02035.
    >> Share

  296. FETZER I, Davis-Gardner ME, Gardner MR, Alfant B, et al
    A coreceptor-mimetic peptide enhances the potency of V3-glycan antibodies.
    J Virol. 2018 Dec 12. pii: JVI.01653-18. doi: 10.1128/JVI.01653.
    >> Share

  297. CHEA LS, Wyatt LS, Gangadhara S, Moss B, et al
    Novel MVA Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses.
    J Virol. 2018 Dec 12. pii: JVI.01648-18. doi: 10.1128/JVI.01648.
    >> Share

  298. ZHANG Y, Chapman JH, Ulcay A, Sutton RE, et al
    Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV.
    J Virol. 2018 Dec 5. pii: JVI.01446-18. doi: 10.1128/JVI.01446.
    >> Share

  299. DANTAS E, Diaz FE, Gerber PP, Varese A, et al
    Histidine-rich glycoprotein inhibits HIV-1 infection in a pH-dependent manner.
    J Virol. 2018 Dec 5. pii: JVI.01749-18. doi: 10.1128/JVI.01749.
    >> Share

    November 2018
  300. ANGIUS F, Smuts H, Rybkina K, Stelitano D, et al
    Analysis of a subacute sclerosing panencephalitis (SSPE) Genotype B3 virus from the 2009/10 South African measles epidemic shows hyperfusogenic F proteins contribute to measles virus infection in the brain.
    J Virol. 2018 Nov 28. pii: JVI.01700-18. doi: 10.1128/JVI.01700.
    >> Share

  301. RINGE RP, Pugach P, Cottrell CA, LaBranche CC, et al
    Closing and opening holes in the glycan shield of HIV-1 envelope glycoprotein SOSIP trimers can redirect the neutralizing antibody response to the newly unmasked epitopes.
    J Virol. 2018 Nov 28. pii: JVI.01656-18. doi: 10.1128/JVI.01656.
    >> Share

  302. ROSAS-UMBERT M, Llano A, Bellido R, Olvera A, et al
    Mechanisms of abrupt loss of virus control in a cohort of previous HIV controllers.
    J Virol. 2018 Nov 28. pii: JVI.01436-18. doi: 10.1128/JVI.01436.
    >> Share

  303. HELMOLD HAIT S, Vargas-Inchaustegui DA, Musich T, Mohanram V, et al
    Early T follicular helper cell responses and germinal center reactions are associated with viremia control in immunized Rhesus macaques.
    J Virol. 2018 Nov 21. pii: JVI.01687-18. doi: 10.1128/JVI.01687.
    >> Share

  304. BENNION BG, Ingle H, Ai TL, Miner CA, et al
    A human gain-of-function STING mutation causes immunodeficiency and gammaherpesvirus-induced pulmonary fibrosis in mice.
    J Virol. 2018 Nov 21. pii: JVI.01806-18. doi: 10.1128/JVI.01806.
    >> Share

  305. WANG Y, Chen X, Xie J, Zhou S, et al
    RNA helicase A is an important host factor involved in dengue virus replication.
    J Virol. 2018 Nov 21. pii: JVI.01306-18. doi: 10.1128/JVI.01306.
    >> Share

  306. CASTILLO-MENENDEZ LR, Nguyen HT, Sodroski J
    Conformational Differences Between Functional Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Trimers and Stabilized Soluble Trimers.
    J Virol. 2018 Nov 14. pii: JVI.01709-18. doi: 10.1128/JVI.01709.
    >> Share

  307. ANAND SP, Prevost J, Baril S, Richard J, et al
    Two families of Env antibodies efficiently engage Fc-gamma receptors and eliminate HIV-1-infected cells.
    J Virol. 2018 Nov 14. pii: JVI.01823-18. doi: 10.1128/JVI.01823.
    >> Share

  308. ASBACH B, Kibler KV, Kostler J, Perdiguero B, et al
    Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost.
    J Virol. 2018 Nov 14. pii: JVI.01529-18. doi: 10.1128/JVI.01529.
    >> Share

  309. KIBLER KV, Asbach B, Perdiguero B, Garcia-Arriaza J, et al
    Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC.
    J Virol. 2018 Nov 14. pii: JVI.01513-18. doi: 10.1128/JVI.01513.
    >> Share

  310. KUMAR S, Panda H, Makhdoomi MA, Mishra N, et al
    An HIV-1 broadly neutralizing antibody from a clade C infected pediatric elite neutralizer potently neutralizes the contemporaneous and autologous evolving viruses.
    J Virol. 2018 Nov 14. pii: JVI.01495-18. doi: 10.1128/JVI.01495.
    >> Share

  311. STEFIC K, Bouvin-Pley M, Essat A, Visdeloup C, et al
    Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time.
    J Virol. 2018 Nov 7. pii: JVI.01492-18. doi: 10.1128/JVI.01492.
    >> Share

  312. KWAA AKR, Talana CAG, Blankson JN
    Interferon-alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-specific CD8+ T Cells.
    J Virol. 2018 Nov 7. pii: JVI.01541-18. doi: 10.1128/JVI.01541.
    >> Share

  313. LIU Z, Torresilla C, Xiao Y, Nguyen PT, et al
    HIV-1 antisense protein of different clades induces autophagy and associates to the autophagy factor p62.
    J Virol. 2018 Nov 7. pii: JVI.01757-18. doi: 10.1128/JVI.01757.
    >> Share

    October 2018
  314. VAN ROMPAY KK, Hassounah S, Keele BF, Lifson JD, et al
    Dolutegravir monotherapy of simian immunodeficiency virus-infected macaques selects for several patterns of resistance mutations with variable virological outcomes.
    J Virol. 2018 Oct 31. pii: JVI.01189-18. doi: 10.1128/JVI.01189.
    >> Share

  315. PIANTADOSI A, Freije CA, Gosmann C, Ye S, et al
    Metagenomic sequencing of HIV-1 in the blood and female genital tract reveals little quasispecies diversity during acute infection.
    J Virol. 2018 Oct 31. pii: JVI.00804-18. doi: 10.1128/JVI.00804.
    >> Share

  316. APPOURCHAUX R, Delpeuch M, Zhong L, Burlaud-Gaillard J, et al
    Functional mapping of regions involved in the negative imprinting of virion particles infectivity and in target cell protection by the Interferon-Induced Transmembrane Protein 3 (IFITM3) against HIV-1.
    J Virol. 2018 Oct 24. pii: JVI.01716-18. doi: 10.1128/JVI.01716.
    >> Share

  317. LI S, Ahmad I, Shi J, Wang B, et al
    Murine leukemia virus glycosylated Gag reduces murine SERINC5 protein expression at steady-state levels via endosome/lysosome pathway to counteract the SERINC5 antiretroviral activity.
    J Virol. 2018 Oct 24. pii: JVI.01651-18. doi: 10.1128/JVI.01651.
    >> Share

  318. CAI Y, Abdel-Mohsen M, Tomescu C, Xue F, et al
    BCL6 Inhibitor-mediated Downregulation of pSAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation.
    J Virol. 2018 Oct 24. pii: JVI.01073-18. doi: 10.1128/JVI.01073.
    >> Share

  319. LO M, Zhu J, Hansen SG, Carroll T, et al
    Acute infection and subsequent subclinical reactivation of herpes simplex virus-2 after vaginal inoculation of rhesus macaques.
    J Virol. 2018 Oct 17. pii: JVI.01574-18. doi: 10.1128/JVI.01574.
    >> Share

  320. MURAKOSHI H, Kuse N, Akahoshi T, Yu Z, et al
    Broad recognition of circulating HIV-1 by HIV-1-specific CTLs with strong ability to suppress HIV-1 replication.
    J Virol. 2018 Oct 17. pii: JVI.01480-18. doi: 10.1128/JVI.01480.
    >> Share

  321. YI DR, An N, Liu ZL, Xu FW, et al
    Human MxB inhibits the replication of HCV.
    J Virol. 2018 Oct 17. pii: JVI.01285-18. doi: 10.1128/JVI.01285.
    >> Share

  322. JAMES KL, de Silva T, Brown K, Whittle H, et al
    LOW-BIAS RNA SEQUENCING OF THE HIV-2 GENOME FROM BLOOD PLASMA.
    J Virol. 2018 Oct 17. pii: JVI.00677-18. doi: 10.1128/JVI.00677.
    >> Share

  323. ANSTETT K, Brenner B, Mesplede T, Wainberg MA, et al
    Correction for Anstett et al., "HIV-1 Resistance to Dolutegravir Is Affected by Cellular Histone Acetyltransferase Activity".
    J Virol. 2018;92.
    >> Share

  324. SOARE AY, Durham ND, Gopal R, Tweel B, et al
    P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1beta in a human tonsil explant model.
    J Virol. 2018 Oct 10. pii: JVI.01186-18. doi: 10.1128/JVI.01186.
    >> Share

  325. HOANG TN, Harper JL, Pino MC, Wang H, et al
    Bone marrow-derived CD4(+) T cells are depleted in SIV-infected macaques and contribute to the size of the replication competent reservoir on ART.
    J Virol. 2018 Oct 10. pii: JVI.01344-18. doi: 10.1128/JVI.01344.
    >> Share

  326. HARGETT AA, Wei Q, Knoppova B, Hall S, et al
    Defining HIV-1 Envelope N-glycan Microdomains Through Site-specific Heterogeneity Profiles.
    J Virol. 2018 Oct 10. pii: JVI.01177-18. doi: 10.1128/JVI.01177.
    >> Share

  327. KINLOCH NN, Lee GQ, Carlson JM, Jin SW, et al
    Genotypic and Mechanistic Characterization of Subtype-specific HIV Adaptation to Host Cellular Immunity.
    J Virol. 2018 Oct 10. pii: JVI.01502-18. doi: 10.1128/JVI.01502.
    >> Share

    September 2018
  328. STAEHELI P, Haller O
    Human MX2/MxB: a potent interferon-induced post-entry inhibitor of herpesviruses and HIV-1.
    J Virol. 2018 Sep 26. pii: JVI.00709-18. doi: 10.1128/JVI.00709.
    >> Share

  329. DOMINGUEZ-MOLINA B, Machmach K, Perales C, Tarancon-Diez L, et al
    Toll Like Receptor-7 and -9 agonists improve Hepatitis C Virus replication and infectivity inhibition by plasmacytoid dendritic cells.
    J Virol. 2018 Sep 19. pii: JVI.01219-18. doi: 10.1128/JVI.01219.
    >> Share

  330. MACDUFF DA, Baldridge MT, Qaqish AM, Nice TJ, et al
    HOIL1 is essential for the induction of type I and III interferons by MDA5 and regulates persistent murine norovirus infection.
    J Virol. 2018 Sep 12. pii: JVI.01368-18. doi: 10.1128/JVI.01368.
    >> Share

  331. REN Y, Korom M, Truong R, Chan D, et al
    Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs.
    J Virol. 2018 Sep 12. pii: JVI.00895-18. doi: 10.1128/JVI.00895.
    >> Share

  332. PISSANI F, Schulte B, Eller MA, Schultz BT, et al
    Modulation of Vaccine-induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
    J Virol. 2018 Sep 12. pii: JVI.01143-18. doi: 10.1128/JVI.01143.
    >> Share

  333. BOEIJEN LL, Hou J, de Groen RA, Verbon A, et al
    Persistent replication of HIV, HCV and HBV results in distinct gene expression profiles by human NK cells.
    J Virol. 2018 Sep 5. pii: JVI.00575-18. doi: 10.1128/JVI.00575.
    >> Share

  334. KUMAR NA, McBrien JB, Carnathan DG, Mavigner M, et al
    Antibody-mediated CD4 depletion induces homeostatic CD4+ T cell proliferation without detectable virus reactivation in ART-treated SIV-infected macaques.
    J Virol. 2018 Sep 5. pii: JVI.01235-18. doi: 10.1128/JVI.01235.
    >> Share

  335. PAROLINI F, Biswas P, Serena M, Sironi F, et al
    Correction for Parolini et al., "Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity".
    J Virol. 2018;92.
    >> Share

    August 2018
  336. TEODOROF-DIEDRICH C, Spector SA
    Human Immunodeficiency Virus Type-1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.
    J Virol. 2018 Aug 29. pii: JVI.00993-18. doi: 10.1128/JVI.00993.
    >> Share

  337. SHARMA S, Lewinski MK, Guatelli J
    An N-glycosylated form of SERINC5 is specifically incorporated into HIV-1 virions.
    J Virol. 2018 Aug 29. pii: JVI.00753-18. doi: 10.1128/JVI.00753.
    >> Share

  338. WELCH JL, Kaddour H, Schlievert PM, Stapleton JT, et al
    Semen exosomes promote transcriptional silencing of HIV-1 by disrupting NF-kB/Sp1/Tat circuitry.
    J Virol. 2018 Aug 15. pii: JVI.00731-18. doi: 10.1128/JVI.00731.
    >> Share

  339. SUTTON MS, Ellis-Connell A, Moriarty RV, Balgeman AJ, et al
    Acute-phase CD4+ T cell responses targeting invariant viral regions are associated with control of live-attenuated simian immunodeficiency virus.
    J Virol. 2018 Aug 15. pii: JVI.00830-18. doi: 10.1128/JVI.00830.
    >> Share

  340. RANKOVIC S, Ramalho R, Aiken C, Rousso I, et al
    PF74 reinforces the HIV-1 capsid to impair reverse transcription-induced uncoating.
    J Virol. 2018 Aug 8. pii: JVI.00845-18. doi: 10.1128/JVI.00845.
    >> Share

  341. CHONG H, Zhu Y, Yu D, He Y, et al
    Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against HIV-1, HIV-2, and Simian Immunodeficiency Virus.
    J Virol. 2018 Aug 8. pii: JVI.01088-18. doi: 10.1128/JVI.01088.
    >> Share

  342. PHILLIPS B, Van Rompay KKA, Rodriguez-Nieves J, Lorin C, et al
    Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant rhesus macaques.
    J Virol. 2018 Aug 8. pii: JVI.01051-18. doi: 10.1128/JVI.01051.
    >> Share

  343. CARNES SK, Zhou J, Aiken C
    HIV-1 Engages a Dynein-Dynactin-BICD2 Complex for Infection and Transport to the Nucleus.
    J Virol. 2018 Aug 1. pii: JVI.00358-18. doi: 10.1128/JVI.00358.
    >> Share

  344. OSEI KUFFOUR E, Schott K, Jaguva Vasudevan AA, Holler J, et al
    USP18 (UBP43) Abrogates p21-Mediated Inhibition of HIV-1.
    J Virol. 2018 Aug 1. pii: JVI.00592-18. doi: 10.1128/JVI.00592.
    >> Share

  345. WANG Z, Wang W, Cui YC, Pan Q, et al
    HIV-1 employs multiple mechanisms to resist Cas9/sgRNA targeting the viral primer binding site.
    J Virol. 2018 Aug 1. pii: JVI.01135-18. doi: 10.1128/JVI.01135.
    >> Share

  346. ANANG S, Kaushik N, Hingane S, Kumari A, et al
    Potent inhibition of hepatitis E virus release by a cyclic peptide inhibitor of the interaction between viral open reading frame 3 protein and host tumor susceptibility gene 101.
    J Virol. 2018 Aug 1. pii: JVI.00684-18. doi: 10.1128/JVI.00684.
    >> Share

  347. PAN T, Peng Z, Tan L, Zou F, et al
    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Potently Inhibit the Replication of Zika Viruses by Inducing the Degradation of AXL.
    J Virol. 2018 Aug 1. pii: JVI.01018-18. doi: 10.1128/JVI.01018.
    >> Share

    July 2018
  348. PENNINGTON MR, Voorhees IEH, Callaway HM, Dehghanpir SD, et al
    The HIV integrase inhibitor raltegravir inhibits felid alphaherpesvirus 1 (FeHV-1) replication by targeting both DNA replication and late gene expression.
    J Virol. 2018 Jul 25. pii: JVI.00994-18. doi: 10.1128/JVI.00994.
    >> Share

  349. PENG BJ, Carlson JM, Liu MKP, Gao F, et al
    Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection.
    J Virol. 2018 Jul 18. pii: JVI.00711-18. doi: 10.1128/JVI.00711.
    >> Share

  350. SIN SH, Eason AB, Bigi R, Kim Y, et al
    Kaposi sarcoma-associated herpesvirus latency locus renders B cells hyperresponsive to secondary infections.
    J Virol. 2018 Jul 18. pii: JVI.01138-18. doi: 10.1128/JVI.01138.
    >> Share

  351. MILLER-NOVAK LK, Das J, Musich TA, Demberg T, et al
    Analysis of complement-mediated lysis of SIV and SIV-infected cells reveals sex differences in vaccine-induced immune responses in Rhesus macaques.
    J Virol. 2018 Jul 18. pii: JVI.00721-18. doi: 10.1128/JVI.00721.
    >> Share

  352. ALSAHAFI N, Anand SP, Castillo-Menendez L, Verly MM, et al
    SOSIP changes affect human immunodeficiency virus (HIV-1) envelope glycoprotein conformation and CD4 engagement.
    J Virol. 2018 Jul 18. pii: JVI.01080-18. doi: 10.1128/JVI.01080.
    >> Share

  353. MAVIGNER M, Habib J, Deleage C, Rosen E, et al
    SIV persistence in cellular and anatomic reservoirs in ART-suppressed infant rhesus macaques.
    J Virol. 2018 Jul 11. pii: JVI.00562-18. doi: 10.1128/JVI.00562.
    >> Share

  354. CHAN KW, Pan R, Costa M, Gorny MK, et al
    Structural Comparison of Human Anti-HIV-1 gp120 V3 MAbs of the Same Gene Usage Induced by Vaccination and Chronic Infection.
    J Virol. 2018 Jul 11. pii: JVI.00641-18. doi: 10.1128/JVI.00641.
    >> Share

  355. BUFFONE C, Martinez-Lopez A, Fricke T, Opp S, et al
    Nup153 Unlocks the Nuclear Pore Complex for HIV-1 Nuclear Translocation in Non-dividing Cells.
    J Virol. 2018 Jul 11. pii: JVI.00648-18. doi: 10.1128/JVI.00648.
    >> Share

  356. OJWACH DBA, MacMillan D, Reddy T, Novitsky V, et al
    Pol-driven replicative capacity impacts disease progression in HIV-1 subtype C infection.
    J Virol. 2018 Jul 11. pii: JVI.00811-18. doi: 10.1128/JVI.00811.
    >> Share

  357. SCHWARTZ JA, Zhang H, Ende Z, Deymier MJ, et al
    Characterization of the plasmacytoid dendritic cell response to transmitted/founder and non-transmitted variants of HIV-1.
    J Virol. 2018 Jul 11. pii: JVI.00157-18. doi: 10.1128/JVI.00157.
    >> Share

  358. CHIEN H, Alston CI, Dix RD
    Suppressor of Cytokine Signaling (SOCS)1 and SOCS3 Are Stimulated Within the Eye During Experimental Murine Cytomegalovirus Retinitis in Mice With Retrovirus-Induced Immunosuppression.
    J Virol. 2018 Jul 5. pii: JVI.00526-18. doi: 10.1128/JVI.00526.
    >> Share

  359. KHAN SN, Sok D, Tran K, Movsesyan A, et al
    Targeting the HIV-1 spike and co-receptor with bi- and trispecific antibodies for single-component broad inhibition of entry.
    J Virol. 2018 Jul 5. pii: JVI.00384-18. doi: 10.1128/JVI.00384.
    >> Share

  360. HOVANESSIAN AG, Soundaramourty C, Benferhat R, Le Grand R, et al
    Vaccination with the conserved caveolin-1 binding motif in HIV-1 glycoprotein gp41 delays the onset of viral infection and provides partial protection in SHIV-challenged cynomolgus macaques.
    J Virol. 2018 Jul 5. pii: JVI.00370-18. doi: 10.1128/JVI.00370.
    >> Share

  361. NOTO A, Procopio FA, Banga R, Suffiotti M, et al
    CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals.
    J Virol. 2018 Jul 5. pii: JVI.00901-18. doi: 10.1128/JVI.00901.
    >> Share

  362. HEUSINGER E, Deppe K, Sette P, Krapp C, et al
    Preadaptation of SIVsmm facilitated Env-mediated counteraction of human tetherin by HIV-2.
    J Virol. 2018 Jul 5. pii: JVI.00276-18. doi: 10.1128/JVI.00276.
    >> Share

  363. YAN Q, Zhao R, Shen C, Wang F, et al
    Upregulation of miR-711 mediates HIV-1 Vpr promotion of KSHV latency and induction of pro-proliferative/survival cytokines by targeting the Notch/NF-kappaB signaling axis.
    J Virol. 2018 Jul 5. pii: JVI.00580-18. doi: 10.1128/JVI.00580.
    >> Share

    June 2018
  364. DITSE Z, Muenchhoff M, Adland E, Jooste P, et al
    HIV-1 SUBTYPE C INFECTED CHILDREN WITH EXCEPTIONAL NEUTRALIZATION BREADTH EXHIBIT POLYCLONAL RESPONSES TARGETING KNOWN EPITOPES.
    J Virol. 2018 Jun 27. pii: JVI.00878-18. doi: 10.1128/JVI.00878.
    >> Share

  365. SCHILLING M, Bulli L, Weigang S, Graf L, et al
    Human MxB protein is a pan-herpesvirus restriction factor.
    J Virol. 2018 Jun 27. pii: JVI.01056-18. doi: 10.1128/JVI.01056.
    >> Share

  366. BROCCA-COFANO E, Xu C, Wetzel KS, Cottrell ML, et al
    Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques.
    J Virol. 2018 Jun 20. pii: JVI.00576-18. doi: 10.1128/JVI.00576.
    >> Share

  367. XU B, Pan Q, Liang C
    The role of MxB in interferon-alpha mediated inhibition of HIV-1 infection.
    J Virol. 2018 Jun 20. pii: JVI.00422-18. doi: 10.1128/JVI.00422.
    >> Share

  368. MULLER JA, Glockle A, Gawanbacht A, Geyer M, et al
    Reduced Susceptibility to VIRIP-based HIV-1 Entry Inhibitors has a High Genetic Barrier and Severe Fitness Costs.
    J Virol. 2018 Jun 20. pii: JVI.00733-18. doi: 10.1128/JVI.00733.
    >> Share

  369. CHONG H, Xue J, Zhu Y, Cong Z, et al
    Design of Novel HIV-1/2 Fusion Inhibitors with Efficient Therapeutic Efficacy in Rhesus Monkey Models.
    J Virol. 2018 Jun 13. pii: JVI.00775-18. doi: 10.1128/JVI.00775.
    >> Share

  370. BALAMURUGAN A, Ng HL, Yang OO
    Cross-Reactivity Against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones.
    J Virol. 2018 Jun 13. pii: JVI.00617-18. doi: 10.1128/JVI.00617.
    >> Share

  371. DHARAN A, Campbell EM
    The Role of Microtubules and Microtubule Associated Proteins in HIV-1 Infection.
    J Virol. 2018 Jun 13. pii: JVI.00085-18. doi: 10.1128/JVI.00085.
    >> Share

  372. GURUNG S, Preno AN, Dubaut JP, Nadeau H, et al
    Translational Model of Zika Virus Disease in Baboons.
    J Virol. 2018 Jun 6. pii: JVI.00186-18. doi: 10.1128/JVI.00186.
    >> Share

  373. KELLER PW, Morrison O, Vassell R, Weiss CD, et al
    HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    J Virol. 2018 Jun 6. pii: JVI.00583-18. doi: 10.1128/JVI.00583.
    >> Share

  374. NEVOT M, Jordan-Paiz A, Martrus G, Andres C, et al
    HIV-1 Protease Evolvability is Affected by Synonymous Nucleotide Recoding.
    J Virol. 2018 Jun 6. pii: JVI.00777-18. doi: 10.1128/JVI.00777.
    >> Share

  375. MARTINS MA, Tully DC, Pedreno-Lopez N, von Bredow B, et al
    Mamu-B*17+ rhesus macaques vaccinated with env, vif, and nef manifest early control of SIVmac239 replication.
    J Virol. 2018 Jun 6. pii: JVI.00690-18. doi: 10.1128/JVI.00690.
    >> Share

    May 2018
  376. ANTONUCCI JM, Kim SH, St Gelais C, Bonifati S, et al
    SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4(+) T-cells.
    J Virol. 2018 May 23. pii: JVI.00292-18. doi: 10.1128/JVI.00292.
    >> Share

  377. SINGH S, Ramirez-Salazar EG, Doueiri R, Valentin A, et al
    Control of Heterologous SIVsmE660 infection by DNA and Protein Co-immunization Regimens Combined with Different Toll-like Receptor-4 (TLR-4) Based Adjuvants in Macaques.
    J Virol. 2018 May 23. pii: JVI.00281-18. doi: 10.1128/JVI.00281.
    >> Share

  378. KANG ZH, Bricault CA, Borducchi EN, Stephenson KE, et al
    Similar epitope specificities of IgG and IgA antibodies elicited by Ad26 vector prime, Env protein boost immunizations in rhesus monkeys.
    J Virol. 2018 May 23. pii: JVI.00537-18. doi: 10.1128/JVI.00537.
    >> Share

  379. BAIYEGUNHI O, Ndlovu B, Ogunshola F, Ismail N, et al
    Frequencies of circulating Th1-biased T follicular helper cells in acute HIV-1 infection correlate with the development of HIV-specific antibody responses and lower set point viral load.
    J Virol. 2018 May 23. pii: JVI.00659-18. doi: 10.1128/JVI.00659.
    >> Share

  380. CAREY BD, Ammosova T, Pinkham C, Lin X, et al
    Protein Phosphatase 1alpha Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation.
    J Virol. 2018 May 16. pii: JVI.02068-17. doi: 10.1128/JVI.02068.
    >> Share

  381. KUMAR S, Morrison JH, Dingli D, Poeschla E, et al
    HIV-1 activation of innate immunity depends strongly on the intracellular level of TREX1 and sensing of incomplete reverse transcription products.
    J Virol. 2018 May 16. pii: JVI.00001-18. doi: 10.1128/JVI.00001.
    >> Share

  382. JI S, Na L, Ren H, Wang Y, et al
    Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
    J Virol. 2018 May 9. pii: JVI.00499-18. doi: 10.1128/JVI.00499.
    >> Share

  383. ELSAYED H, Nabi G, McKinstry WJ, Khoo KK, et al
    Intrastructural Help: Harnessing T-Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines.
    J Virol. 2018 May 9. pii: JVI.00141-18. doi: 10.1128/JVI.00141.
    >> Share

  384. QIAO J, Cao Y, Zabaleta J, Yang L, et al
    Regulation of virus-associated lymphoma growth and gene expression by bacterial quorum sensing molecules.
    J Virol. 2018 May 9. pii: JVI.00478-18. doi: 10.1128/JVI.00478.
    >> Share

  385. SCINTO HB, Gupta S, Thorat S, Mukhtar MM, et al
    A novel strategy to adapt SHIV-E1 carrying env from an RV144 volunteer to rhesus macaques: coreceptor switch and final recovery of a pathogenic virus with exclusive R5 tropism.
    J Virol. 2018 May 9. pii: JVI.02222-17. doi: 10.1128/JVI.02222.
    >> Share

  386. LODERMEYER V, Ssebyatika G, Passos V, Ponnurangam A, et al
    The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K is Species-Specific.
    J Virol. 2018 May 9. pii: JVI.00226-18. doi: 10.1128/JVI.00226.
    >> Share

  387. MUELLER N, Pasternak AO, Klaver B, Cornelissen M, et al
    The HIV-1 Tat protein enhances splicing at the major splice donor site.
    J Virol. 2018 May 9. pii: JVI.01855-17. doi: 10.1128/JVI.01855.
    >> Share

  388. WENSEL D, Sun Y, Davis J, Li Z, et al
    A Novel gp41-Binding Adnectin with Potent Anti-HIV Activity Is Highly Synergistic when Linked to a CD4-Binding Adnectin.
    J Virol. 2018 May 9. pii: JVI.00421-18. doi: 10.1128/JVI.00421.
    >> Share

  389. MAHDI M, Szojka Z, Motyan JA, Tozser J, et al
    Inhibitory effects of HIV-2 Vpx on replication of HIV-1.
    J Virol. 2018 May 9. pii: JVI.00554-18. doi: 10.1128/JVI.00554.
    >> Share

  390. PALESCH D, Bosinger SE, Mavigner M, Billingsley JM, et al
    Short-term pIFN-alpha2a treatment does not significantly reduce the viral reservoir of SIV-infected, ART-treated rhesus macaques.
    J Virol. 2018 May 2. pii: JVI.00279-18. doi: 10.1128/JVI.00279.
    >> Share

  391. BROZY J, Schlaepfer E, Mueller CKS, Rochat MA, et al
    Antiviral Activity of HIV gp120 Targeting Bispecific T Cell Engager (BiTE(R)) Antibody Constructs.
    J Virol. 2018 May 2. pii: JVI.00491-18. doi: 10.1128/JVI.00491.
    >> Share

  392. HOUZET L, Perez-Losada M, Matusali G, Deleage C, et al
    Seminal SIV in chronically-infected cynomolgus macaques is dominated by virus originating from multiple genital organs.
    J Virol. 2018 May 2. pii: JVI.00133-18. doi: 10.1128/JVI.00133.
    >> Share

  393. ANTHONY C, York T, Bekker V, Matten D, et al
    Correction for Anthony et al., "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope".
    J Virol. 2018;92.
    >> Share

    April 2018
  394. MARTIN JL, Mendonca L, Marusinec R, Zuczek J, et al
    Critical Role of the HTLV-1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly.
    J Virol. 2018 Apr 25. pii: JVI.00333-18. doi: 10.1128/JVI.00333.
    >> Share

  395. OZOROWSKI G, Cupo A, Golabek M, LoPiccolo M, et al
    Effects of adjuvants on HIV-1 envelope glycoprotein SOSIP trimers in vitro.
    J Virol. 2018 Apr 18. pii: JVI.00381-18. doi: 10.1128/JVI.00381.
    >> Share

  396. PAPARISTO E, Woods MW, Coleman MD, Moghadasi SA, et al
    Evolution-guided structural and functional analyses of the HERC family reveals an ancient marine origin and determinants of antiviral activity.
    J Virol. 2018 Apr 18. pii: JVI.00528-18. doi: 10.1128/JVI.00528.
    >> Share

  397. PREVOST J, Richard J, Medjahed H, Alexander A, et al
    Incomplete downregulation of CD4 expression affects HIV-1 Env conformation and ADCC responses.
    J Virol. 2018 Apr 18. pii: JVI.00484-18. doi: 10.1128/JVI.00484.
    >> Share

  398. BRICAULT CA, Kovacs JM, Badamchi-Zadeh A, McKee K, et al
    Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.
    J Virol. 2018 Apr 11. pii: JVI.00369-18. doi: 10.1128/JVI.00369.
    >> Share

  399. REZAEI SD, Lu HK, Chang JJ, Rhodes A, et al
    The pathway to establishing HIV latency is critical to how latency is maintained and reversed.
    J Virol. 2018 Apr 11. pii: JVI.02225-17. doi: 10.1128/JVI.02225.
    >> Share

  400. POLICICCHIO BB, Cardozo EF, Sette P, Xu C, et al
    The dynamics of SIV 2-LTR Circles in the Presence and Absence of CD8(+) Cells.
    J Virol. 2018 Apr 11. pii: JVI.02100-17. doi: 10.1128/JVI.02100.
    >> Share

  401. LUO X, Yang W, Gao G
    SUN1 regulates HIV-1 nuclear import in a manner dependent on the interaction between the viral capsid and cellular cyclophilin A.
    J Virol. 2018 Apr 11. pii: JVI.00229-18. doi: 10.1128/JVI.00229.
    >> Share

  402. DELUCIA DC, Rinaldo CR, Rappocciolo G
    Inefficient HIV-1 trans infection of CD4(+) T cells by macrophages from HIV-1 nonprogressors is associated with altered membrane cholesterol and DC-SIGN.
    J Virol. 2018 Apr 11. pii: JVI.00092-18. doi: 10.1128/JVI.00092.
    >> Share

  403. NING J, Zhong Z, Fischer DK, Harris G, et al
    Truncated CPSF6 forms higher order complexes that bind and disrupt HIV-1 capsid.
    J Virol. 2018 Apr 11. pii: JVI.00368-18. doi: 10.1128/JVI.00368.
    >> Share

  404. NATESAMPILLAI S, Cummins NW, Nie Z, Sampath R, et al
    The proapoptotic, HIV protease generated Casp8p41 when bound and inactivated by Bcl2, is degraded by the proteasome.
    J Virol. 2018 Apr 11. pii: JVI.00037-18. doi: 10.1128/JVI.00037.
    >> Share

  405. BOYER PL, Smith SJ, Zhao XZ, Das K, et al
    Developing and evaluating inhibitors against the RNase H active site of HIV-1 RT.
    J Virol. 2018 Apr 11. pii: JVI.02203-17. doi: 10.1128/JVI.02203.
    >> Share

  406. WANG J, Shaban NM, Land AM, Brown WL, et al
    SIVmac239 Vif and Human APOBEC3B Interactions Resemble Those Between HIV-1 Vif and Human APOBEC3G.
    J Virol. 2018 Apr 4. pii: JVI.00447-18. doi: 10.1128/JVI.00447.
    >> Share

  407. SHENOY A, Dwork A, Elkind MSV, Marshall R, et al
    Brain large artery lymphocytic inflammation and Human Immunodeficiency Virus-related brain arterial remodeling.
    J Virol. 2018 Apr 4. pii: JVI.00081-18. doi: 10.1128/JVI.00081.
    >> Share

  408. MOYO T, Ereno-Orbea J, Jacob RA, Pavillet CE, et al
    Molecular basis of unusually high neutralization resistance in tier 3 HIV-1 strain 253-11.
    J Virol. 2018 Apr 4. pii: JVI.02261-17. doi: 10.1128/JVI.02261.
    >> Share

  409. CASTILLO-MENENDEZ LR, Witt K, Espy N, Princiotto A, et al
    Comparison of Uncleaved and Mature Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimers.
    J Virol. 2018 Apr 4. pii: JVI.00277-18. doi: 10.1128/JVI.00277.
    >> Share

    March 2018
  410. FETZER I, Gardner MR, Davis-Gardner ME, Prasad NR, et al
    eCD4-Ig variants that more potently neutralize HIV-1.
    J Virol. 2018 Mar 28. pii: JVI.02011-17. doi: 10.1128/JVI.02011.
    >> Share

  411. STRONGIN Z, Sharaf R, VanBelzen DJ, Jacobson JM, et al
    EFFECT OF SHORT-TERM ART INTERRUPTION ON LEVELS OF INTEGRATED HIV DNA.
    J Virol. 2018 Mar 28. pii: JVI.00285-18. doi: 10.1128/JVI.00285.
    >> Share

  412. HARKER JA, Wong KA, Dallari S, Bao P, et al
    IL-27R signalling mediates early viral containment and impacts innate and adaptive immunity after chronic lymphocytic choriomeningitis virus infection.
    J Virol. 2018 Mar 28. pii: JVI.02196-17. doi: 10.1128/JVI.02196.
    >> Share

  413. SALGADO M, Garcia-Minambres A, Dalmau J, Jimenez-Moyano E, et al
    Control of HIV-1 pathogenesis in viremic nonprogressors is independent of Gag-specific CTL responses.
    J Virol. 2018 Mar 28. pii: JVI.00346-18. doi: 10.1128/JVI.00346.
    >> Share

  414. GARRIDO C, Abad-Fernandez M, Tuyishime M, Pollara JJ, et al
    IL-15 STIMULATED NATURAL KILLER CELLS CLEAR HIV-1 INFECTED CELLS FOLLOWING LATENCY REVERSAL EX VIVO.
    J Virol. 2018 Mar 28. pii: JVI.00235-18. doi: 10.1128/JVI.00235.
    >> Share

  415. HSU DC, Sunyakumthorn P, Wegner M, Schuetz A, et al
    Central Nervous System Inflammation and Infection During Early, Non-Accelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques.
    J Virol. 2018 Mar 21. pii: JVI.00222-18. doi: 10.1128/JVI.00222.
    >> Share

  416. CASCAJERO A, Rastrojo A, Diez-Fuertes F, Hernandez-Novoa B, et al
    Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.
    J Virol. 2018 Mar 21. pii: JVI.00390-18. doi: 10.1128/JVI.00390.
    >> Share

  417. HESSELL AJ, Shapiro MB, Powell R, Malherbe DC, et al
    Reduced cell-associated DNA and improved viral control in macaques following passive transfer of a single anti-V2 monoclonal antibody and repeated SHIV challenges.
    J Virol. 2018 Mar 7. pii: JVI.02198-17. doi: 10.1128/JVI.02198.
    >> Share

  418. KRISTENSEN AB, Kent SJ, Parsons MS
    Contribution of NK cell education to both direct and anti-HIV-1 antibody-dependent NK cell functions.
    J Virol. 2018 Mar 7. pii: JVI.02146-17. doi: 10.1128/JVI.02146.
    >> Share

  419. SHI J, Xiong R, Zhou T, Su P, et al
    HIV-1 Nef antagonizes SERINC5 restriction by downregulation of SERINC5 via the endosome/lysosome system.
    J Virol. 2018 Mar 7. pii: JVI.00196-18. doi: 10.1128/JVI.00196.
    >> Share

    February 2018
  420. PANASIUK M, Rychlowski M, Derewonko N, Bienkowska-Szewczyk K, et al
    Tunneling nanotubes (TNT) as a novel route of cell-to-cell spread of herpesviruses.
    J Virol. 2018 Feb 28. pii: JVI.00090-18. doi: 10.1128/JVI.00090.
    >> Share

  421. HUAN C, Li Z, Ning S, Wang H, et al
    Long non-coding RNA uc002yug.2 activates HIV-1 latency through regulating mRNA level of various RUNX1 isoforms and increasing Tat expression.
    J Virol. 2018 Feb 28. pii: JVI.01844-17. doi: 10.1128/JVI.01844.
    >> Share

  422. CARNATHAN DG, Mackel JJ, Sweat SL, Enemuo CA, et al
    Intragastric administration of Lactobacillus plantarum and AT-2-inactivated SIV does not protect Indian rhesus macaques from intra-rectal SIV challenge nor reduce virus replication after transmission.
    J Virol. 2018 Feb 28. pii: JVI.02030-17. doi: 10.1128/JVI.02030.
    >> Share

  423. ASHOKKUMAR M, Aralaguppe SG, Tripathy SP, Hanna LE, et al
    Unique phenotypic characteristics of recently transmitted HIV-1 subtype C envelope glycoprotein gp120: Use of CXCR6 co-receptor by transmitted founder viruses.
    J Virol. 2018 Feb 28. pii: JVI.00063-18. doi: 10.1128/JVI.00063.
    >> Share

  424. REED JC, Westergreen N, Barajas BC, Ressler DTB, et al
    The formation of RNA granule-derived capsid assembly intermediates appears to be conserved between HIV-1 and the non-primate lentivirus FIV.
    J Virol. 2018 Feb 21. pii: JVI.01761-17. doi: 10.1128/JVI.01761.
    >> Share

  425. CARNATHAN D, Lawson B, Yu J, Patel K, et al
    Reduced chronic lymphocyte activation following Interferon-alpha blockade in the acute phase of SIV infection in rhesus macaques.
    J Virol. 2018 Feb 21. pii: JVI.01760-17. doi: 10.1128/JVI.01760.
    >> Share

  426. WANG C, Zhou H, Xue Y, Liang J, et al
    Epstein-Barr Virus Nuclear Antigen Leader protein co-activates EP300.
    J Virol. 2018 Feb 21. pii: JVI.02155-17. doi: 10.1128/JVI.02155.
    >> Share

  427. MADRID-ELENA N, Garcia-Bermejo ML, Serrano-Villar S, Diaz-de Santiago A, et al
    Maraviroc is associated with latent HIV-1 reactivation through NF-kappaB activation in resting CD4(+) T cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    J Virol. 2018 Feb 14. pii: JVI.01931-17. doi: 10.1128/JVI.01931.
    >> Share

  428. SAUNDERS KO, Santra S, Parks R, Yates NL, et al
    Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates.
    J Virol. 2018 Feb 7. pii: JVI.02035-17. doi: 10.1128/JVI.02035.
    >> Share

  429. BIRYUKOV J, Meyers C
    Superinfection Exclusion between Two High-Risk Human Papillomavirus (HPV) Types During a Co-Infection.
    J Virol. 2018 Feb 7. pii: JVI.01993-17. doi: 10.1128/JVI.01993.
    >> Share

    January 2018
  430. CHEUNG KW, Wu T, Ho SF, Wong YC, et al
    alpha4beta7(+) CD4(+) effector/effector memory T cells differentiate into productively and latently infected central memory T cells by TGFbeta1 during HIV-1 infection.
    J Virol. 2018 Jan 31. pii: JVI.01510-17. doi: 10.1128/JVI.01510.
    >> Share

  431. YATES NL, deCamp AC, Korber BT, Liao HX, et al
    HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.
    J Virol. 2018 Jan 31. pii: JVI.01843-17. doi: 10.1128/JVI.01843.
    >> Share

  432. RUJAS E, Leaman DP, Insausti S, Ortigosa-Pascual L, et al
    FUNCTIONAL OPTIMIZATION OF BROADLY NEUTRALIZING HIV-1 ANTIBODY 10E8 BY PROMOTING MEMBRANE INTERACTIONS.
    J Virol. 2018 Jan 31. pii: JVI.02249-17. doi: 10.1128/JVI.02249.
    >> Share

  433. OVERBAUGH J
    Defining the barriers to women publishing in high-impact journals.
    J Virol. 2018 Jan 24. pii: JVI.02127-17. doi: 10.1128/JVI.02127.
    >> Share

  434. TORRENTS DE LA PENA A, de Taeye SW, Sliepen K, LaBranche CC, et al
    Immunogenicity in rabbits of SOSIP trimers from clades A, B and C, given individually, sequentially or in combinations.
    J Virol. 2018 Jan 24. pii: JVI.01957-17. doi: 10.1128/JVI.01957.
    >> Share

  435. SATHEESAN S, Li H, Burnett JC, Takahashi M, et al
    HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational ART.
    J Virol. 2018 Jan 17. pii: JVI.02118-17. doi: 10.1128/JVI.02118.
    >> Share

  436. ABNER E, Stoszko M, Zeng L, Chen HC, et al
    A new quinoline BRD4 inhibitor targets a distinct latent HIV-1 reservoir for re-activation from other 'shock' drugs.
    J Virol. 2018 Jan 17. pii: JVI.02056-17. doi: 10.1128/JVI.02056.
    >> Share

  437. PAN R, Qin Y, Banasik M, Lees W, et al
    Increased epitope complexity correlated with antibody affinity maturation and a novel binding mode revealed by structures of rabbit antibodies against the third variable loop (V3) of HIV-1 gp120.
    J Virol. 2018 Jan 17. pii: JVI.01894-17. doi: 10.1128/JVI.01894.
    >> Share

  438. ITA S, Hill AK, Lam EC, Dufort FJ, et al
    High-Resolution Sequencing of Viral Populations During Early SIV Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses.
    J Virol. 2018 Jan 17. pii: JVI.01574-17. doi: 10.1128/JVI.01574.
    >> Share

  439. WU X, Liu Z, Ding X, Yu D, et al
    Mechanism of HIV-1 Resistance to an Electronically Constrained alpha-Helical Peptide Membrane Fusion Inhibitor.
    J Virol. 2018 Jan 10. pii: JVI.02044-17. doi: 10.1128/JVI.02044.
    >> Share

  440. MISRA A, Gleeson E, Wang W, Ye C, et al
    Glycosyl-phosphatidylinositol-Anchored Anti-HIV Env Single Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.
    J Virol. 2018 Jan 10. pii: JVI.02080-17. doi: 10.1128/JVI.02080.
    >> Share

  441. ST GELAIS C, Kim SH, Maksimova VV, Buzovetsky O, et al
    A Cyclin-binding Motif in Human SAMHD1 Is Required for Its HIV-1 Restriction, dNTPase Activity, Tetramer Formation, and Efficient Phosphorylation.
    J Virol. 2018 Jan 10. pii: JVI.01787-17. doi: 10.1128/JVI.01787.
    >> Share

  442. EVANS EL 3RD, Becker JT, Fricke SL, Patel K, et al
    HIV-1 Vif's capacity to manipulate the cell cycle is species-specific.
    J Virol. 2018 Jan 10. pii: JVI.02102-17. doi: 10.1128/JVI.02102.
    >> Share

  443. WILLS S, Hwang KK, Liu P, Dennison SM, et al
    HIV-1 specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galcer Blocking and Phagocytosis.
    J Virol. 2018 Jan 10. pii: JVI.01552-17. doi: 10.1128/JVI.01552.
    >> Share

  444. ENDE Z, Deymier MJ, Claiborne DT, Prince JL, et al
    HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
    J Virol. 2018 Jan 10. pii: JVI.01633-17. doi: 10.1128/JVI.01633.
    >> Share

  445. BADAMCHI-ZADEH A, Tartaglia LJ, Abbink P, Bricault CA, et al
    Therapeutic efficacy of vectored PGT121 gene delivery in HIV-1-infected humanized mice.
    J Virol. 2018 Jan 10. pii: JVI.01925-17. doi: 10.1128/JVI.01925.
    >> Share

  446. ZAIKOS TD, Painter MM, Sebastian NT, Terry VH, et al
    Class 1-selective histone deacetylase inhibitors enhance HIV latency reversal while preserving the activity of HDAC isoforms necessary for maximal HIV gene expression.
    J Virol. 2018 Jan 3. pii: JVI.02110-17. doi: 10.1128/JVI.02110.
    >> Share

  447. HRABER P, Rademeyer C, Williamson C, Seaman MS, et al
    Correction for Hraber et al., "Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments".
    J Virol. 2017;92.
    >> Share

    December 2017
  448. GU Q, Zhang Z, Gertzen CGW, Haussinger D, et al
    Identification of a conserved interface of HIV-1 and FIV Vifs with Cullin 5.
    J Virol. 2017 Dec 20. pii: JVI.01697-17. doi: 10.1128/JVI.01697.
    >> Share

  449. ZHOU R, Wang X, Liu H, Guo L, et al
    GalNAc-Specific Soybean Lectin Inhibits HIV Infection of Macrophages through Induction of Antiviral Factors.
    J Virol. 2017 Dec 20. pii: JVI.01720-17. doi: 10.1128/JVI.01720.
    >> Share

  450. LIANG R, Sun Y, Liu Y, Wang J, et al
    Major histocompatibility complex class I (FLA-E*01801) molecular structure in domestic cats demonstrates species-specific characteristics in presenting viral antigen peptides.
    J Virol. 2017 Dec 20. pii: JVI.01631-17. doi: 10.1128/JVI.01631.
    >> Share

  451. FRICKE T, Brandariz-Nunez A, Wang X, Smith AB 3rd, et al
    Correction for Fricke et al., "Human Cytosolic Extracts Stabilize the HIV-1 Core".
    J Virol. 2017;91.
    >> Share

  452. JONES AT, Chamcha V, Kesavardhana S, Shen X, et al
    A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques.
    J Virol. 2017 Dec 13. pii: JVI.01796-17. doi: 10.1128/JVI.01796.
    >> Share

  453. MORGER D, Zosel F, Buhlmann M, Zuger S, et al
    The three-fold axis of the HIV-1 capsid lattice is the species-specific binding interface for TRIM5alpha.
    J Virol. 2017 Dec 13. pii: JVI.01541-17. doi: 10.1128/JVI.01541.
    >> Share

  454. CHIKATA T, Van Tran G, Murakoshi H, Akahoshi T, et al
    HLA class I-mediated HIV-1 control in Vietnamese infected with HIV-1 subtype A/E.
    J Virol. 2017 Dec 13. pii: JVI.01749-17. doi: 10.1128/JVI.01749.
    >> Share

  455. COHEN YZ, Lorenzi JCC, Seaman MS, Nogueira L, et al
    Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells.
    J Virol. 2017 Dec 13. pii: JVI.01883-17. doi: 10.1128/JVI.01883.
    >> Share

  456. SCHOUEST B, Weiler AM, Janaka SK, Myers TA, et al
    Maintenance of AP-2 Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.
    J Virol. 2017 Dec 13. pii: JVI.01822-17. doi: 10.1128/JVI.01822.
    >> Share

  457. QUALLS ZM, Choudhary A, Honnen W, Prattipati R, et al
    Identification of novel structural determinants in MW965 Env that regulate the neutralization phenotype and conformational masking potential of primary HIV-1 isolates.
    J Virol. 2017 Dec 13. pii: JVI.01779-17. doi: 10.1128/JVI.01779.
    >> Share

  458. PERNAS M, Tarancon-Diez L, Rodriguez-Gallego E, Gomez J, et al
    Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
    J Virol. 2017 Dec 6. pii: JVI.01805-17. doi: 10.1128/JVI.01805.
    >> Share

  459. KIRSCHMAN J, Qi M, Ding L, Hammonds J, et al
    HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment is Required for Particle Incorporation.
    J Virol. 2017 Dec 6. pii: JVI.01893-17. doi: 10.1128/JVI.01893.
    >> Share

  460. SATO K, Misawa N, Takeuchi JS, Kobayashi T, et al
    Experimental adaptive evolution of SIVcpz to pandemic HIV-1 using a humanized mouse model.
    J Virol. 2017 Dec 6. pii: JVI.01905-17. doi: 10.1128/JVI.01905.
    >> Share

  461. YOON CH, Kim SY, Byeon SE, Jeong Y, et al
    Correction for Yoon et al., "p53-Derived Host Restriction of HIV-1 Replication by Protein Kinase R-Mediated Tat Phosphorylation and Inactivation".
    J Virol. 2017;91.
    >> Share

    November 2017
  462. DE VERNEUIL A, Migraine J, Mammano F, Molina JM, et al
    Genetically intact but functionally impaired HIV-1 Env glycoproteins in the T-cell reservoir.
    J Virol. 2017 Nov 29. pii: JVI.01684-17. doi: 10.1128/JVI.01684.
    >> Share

  463. WAGNER JM, Christensen DE, Bhattacharya A, Dawidziak DM, et al
    A general model for retroviral capsid pattern recognition by TRIM5 proteins.
    J Virol. 2017 Nov 29. pii: JVI.01563-17. doi: 10.1128/JVI.01563.
    >> Share

  464. ADLAND E, Hill M, Lavandier N, Csala A, et al
    DIFFERENTIAL IMMUNODOMINANCE HIERARCHY OF CD8+ T CELL RESPONSES IN HLA-B*27:05 AND B*27:02-MEDIATED CONTROL OF HIV-1 INFECTION.
    J Virol. 2017 Nov 22. pii: JVI.01685-17. doi: 10.1128/JVI.01685.
    >> Share

  465. CHAILLON A, Gianella S, Lada SM, Perez-Santiago J, et al
    Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.
    J Virol. 2017 Nov 15. pii: JVI.01589-17. doi: 10.1128/JVI.01589.
    >> Share

  466. WHITE E, Wu F, Chertova E, Bess J, et al
    Truncating the Gp41 Cytoplasmic Tail of SIV Decreases Sensitivity to Neutralizing Antibodies without Increasing Envelope Content of Virions.
    J Virol. 2017 Nov 15. pii: JVI.01688-17. doi: 10.1128/JVI.01688.
    >> Share

  467. ELLIS-CONNELL AL, Balgeman AJ, Zarbock KR, Barry G, et al
    ALT-803 transiently reduces SIV replication in the absence of antiretroviral treatment.
    J Virol. 2017 Nov 8. pii: JVI.01748-17. doi: 10.1128/JVI.01748.
    >> Share

  468. PINKEVYCH M, Fennessey CM, Cromer D, Tolstrup M, et al
    Estimating initial viral levels during HIV/SIV reactivation from latency.
    J Virol. 2017 Nov 8. pii: JVI.01667-17. doi: 10.1128/JVI.01667.
    >> Share

  469. QUITADAMO B, Peters PJ, Repik A, O'Connell O, et al
    HIV-1 R5 macrophage-tropic envelope glycoprotein trimers bind CD4 with high affinity, while the CD4 binding site on non-macrophage-tropic, T- tropic R5 envelopes is occluded.
    J Virol. 2017 Nov 8. pii: JVI.00841-17. doi: 10.1128/JVI.00841.
    >> Share

  470. SOTO-NAVA M, Avila-Rios S, Valenzuela-Ponce H, Garcia-Morales C, et al
    Weaker HLA footprints on HIV in the unique and highly genetically admixed host population of Mexico.
    J Virol. 2017 Nov 1. pii: JVI.01128-17. doi: 10.1128/JVI.01128.
    >> Share

  471. MALHERBE DC, Mendy J, Vang L, Barnette PT, et al
    Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C SHIV Mucosal Challenge.
    J Virol. 2017 Nov 1. pii: JVI.01092-17. doi: 10.1128/JVI.01092.
    >> Share

  472. PAYNE EH, Ramalingam D, Fox DT, Klotman ME, et al
    Polyploidy And Mitotic Cell Death Are Two Distinct HIV-1 Vpr-Driven Outcomes In Renal Tubule Epithelial Cells.
    J Virol. 2017 Nov 1. pii: JVI.01718-17. doi: 10.1128/JVI.01718.
    >> Share

  473. ARACHCHIGE SP, Henke W, Pramanik A, Kalamvoki M, et al
    Analysis of Select HSV-1 Proteins for Restriction of Human Immunodeficiency Virus Type 1: The HSV-1 gM Protein Potently Restricts HIV-1 by Preventing the Intracellular Transport and Processing of Env gp160.
    J Virol. 2017 Nov 1. pii: JVI.01476-17. doi: 10.1128/JVI.01476.
    >> Share

    October 2017
  474. PAROLINI F, Biswas P, Serena M, Sironi F, et al
    Stability and expression levels of HLA-C on the cell membrane modulate HIV-1 infectivity.
    J Virol. 2017 Oct 25. pii: JVI.01711-17. doi: 10.1128/JVI.01711.
    >> Share

  475. KASMAPOUR B, Kubsch T, Rand U, Eiz-Vesper B, et al
    Myeloid dendritic cells repress human cytomegalovirus gene expression and spread by releasing interferon-unrelated soluble antiviral factors.
    J Virol. 2017 Oct 18. pii: JVI.01138-17. doi: 10.1128/JVI.01138.
    >> Share

  476. YOUNG GR, Terry SN, Manganaro L, Cuesta-Dominguez A, et al
    HIV-1 infection of primary CD4+ T cells regulates the expression of specific HERV-K (HML-2) elements.
    J Virol. 2017 Oct 18. pii: JVI.01507-17. doi: 10.1128/JVI.01507.
    >> Share

  477. MWIMANZI F, Toyoda M, Mahiti M, Mann JK, et al
    Relative resistance of MHC-B to Nef-mediated downregulation is conserved among primate lentiviruses and influences antiviral T cell responses in HIV-1-infected individuals.
    J Virol. 2017 Oct 18. pii: JVI.01409-17. doi: 10.1128/JVI.01409.
    >> Share

  478. MCGUIRE EP, Fong Y, Toote C, Cunningham CK, et al
    HIV exposed infants vaccinated with a MF59/rgp120 vaccine have higher magnitude anti-V1V2 IgG responses than adults immunized with the same vaccine.
    J Virol. 2017 Oct 11. pii: JVI.01070-17. doi: 10.1128/JVI.01070.
    >> Share

  479. CROMER D, Pinkevych M, Rasmussen TA, Lewin SR, et al
    Modelling of anti-latency treatment in HIV; What is the optimal duration of anti-retroviral-free HIV remission?
    J Virol. 2017 Oct 11. pii: JVI.01395-17. doi: 10.1128/JVI.01395.
    >> Share

  480. PAINTER MM, Zaikos TD, Collins KL
    Quiescence promotes latent HIV infection and resistance to reactivation from latency with histone deacetylase inhibitors.
    J Virol. 2017 Oct 11. pii: JVI.01080-17. doi: 10.1128/JVI.01080.
    >> Share

  481. SHEN X, Basu R, Sawant S, Beaumont D, et al
    HIV-1 gp120 Protein and MVAgp140 Boost Immunogens Increase immunogenicity of a DNA/MVA HIV-1 Vaccine.
    J Virol. 2017 Oct 11. pii: JVI.01077-17. doi: 10.1128/JVI.01077.
    >> Share

  482. BRACQ L, Xie M, Lambele M, Vu LT, et al
    T cell-macrophage fusion triggers multinucleated giant cell formation for HIV-1 spreading.
    J Virol. 2017 Oct 4. pii: JVI.01237-17. doi: 10.1128/JVI.01237.
    >> Share

  483. GIFT SK, Leaman DP, Zhang L, Kim AS, et al
    Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at its Apex.
    J Virol. 2017 Oct 4. pii: JVI.01216-17. doi: 10.1128/JVI.01216.
    >> Share

    September 2017
  484. MARRAS F, Casabianca A, Bozzano F, Ascierto ML, et al
    Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.
    J Virol. 2017 Sep 27. pii: JVI.00647-17. doi: 10.1128/JVI.00647.
    >> Share

  485. FAUTEUX-DANIEL S, Larouche A, Calderon V, Boulais J, et al
    Vertical transmission of hepatitis C virus: variable transmission bottleneck and evidence of mid-gestation in utero infection.
    J Virol. 2017 Sep 20. pii: JVI.01372-17. doi: 10.1128/JVI.01372.
    >> Share

  486. GALVIS AE, Fisher HE, Fan H, Camerini D, et al
    Conformational Changes in the 5' End of the HIV-1 Genome Dependent on the Debranching Enzyme DBR1 During Early Stages of Infection.
    J Virol. 2017 Sep 20. pii: JVI.01377-17. doi: 10.1128/JVI.01377.
    >> Share

  487. VALLE-CASUSO JC, Allouch A, David A, Lenzi GM, et al
    p21 restricts HIV-1 in monocyte-derived dendritic cells through the reduction of dNTP biosynthesis and regulation of SAMHD1 antiviral activity.
    J Virol. 2017 Sep 20. pii: JVI.01324-17. doi: 10.1128/JVI.01324.
    >> Share

  488. CONTRERAS-GALINDO RA, Dube D, Fujinaga K, Kaplan MH, et al
    Susceptibility of Human Endogenous Retrovirus Type-K to Reverse Transcriptase Inhibitors.
    J Virol. 2017 Sep 20. pii: JVI.01309-17. doi: 10.1128/JVI.01309.
    >> Share

  489. RIFE MAGALIS B, Nolan DJ, Autissier P, Burdo TH, et al
    Insights into the impact of CD8+ immune modulation on HIV evolutionary dynamics in distinct anatomical compartments using SIV-infected macaque models of AIDS progression.
    J Virol. 2017 Sep 20. pii: JVI.01162-17. doi: 10.1128/JVI.01162.
    >> Share

  490. BROCCA-COFANO E, Kuhrt D, Siewe B, Xu C, et al
    Pathogenic Correlates of the Simian Immunodeficiency Virus (SIV)-Associated B Cell Dysfunction.
    J Virol. 2017 Sep 20. pii: JVI.01051-17. doi: 10.1128/JVI.01051.
    >> Share

  491. BOMSEL M, Ganor Y
    Calcitonin gene-related peptide induces HIV-1 proteasomal degradation in mucosal Langerhans cells.
    J Virol. 2017 Sep 13. pii: JVI.01205-17. doi: 10.1128/JVI.01205.
    >> Share

  492. TEIGLER JE, Zelinskyy G, Eller MA, Bolton DL, et al
    Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
    J Virol. 2017 Sep 13. pii: JVI.01263-17. doi: 10.1128/JVI.01263.
    >> Share

  493. LITTWITZ-SALOMON E, Schimmer S, Dittmer U
    The dose of retroviral infection determines the induction of anti-viral NK cell responses.
    J Virol. 2017 Sep 13. pii: JVI.01122-17. doi: 10.1128/JVI.01122.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016